Browse by UCL Departments and Centres
A
Aamodt, AH;
Høgestøl, EA;
Popperud, TH;
Holter, JC;
Dyrhol-Riise, AM;
Tonby, K;
Stiksrud, B;
... Harbo, HF; + view all
(2021)
Blood neurofilament light concentration at admittance: a potential prognostic marker in COVID-19.
Journal of Neurology
10.1007/s00415-021-10517-6.
(In press).
|
Ahmed, RM;
Bocchetta, M;
Todd, EG;
Tse, NY;
Devenney, EM;
Tu, S;
Caga, J;
... Rohrer, JD; + view all
(2021)
Tackling clinical heterogeneity across the Amyotrophic Lateral Sclerosis-Frontotemporal Dementia spectrum using a transdiagnostic approach.
Brain Communications
10.1093/braincomms/fcab257.
(In press).
|
Al Khleifat, A;
Balendra, R;
Fang, T;
Al-Chalabi, A;
(2021)
Intuitive Staging Correlates With King's Clinical Stage.
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
10.1080/21678421.2020.1867181.
(In press).
|
Alagaratnam, J;
De Francesco, D;
Zetterberg, H;
Heslegrave, A;
Toombs, J;
Kootstra, NA;
Underwood, J;
... Winston, A; + view all
(2021)
Correlation between cerebrospinal fluid and plasma neurofilament light protein in treated HIV infection: results from the COBRA study.
Journal of NeuroVirology
10.1007/s13365-021-01026-3.
(In press).
|
Alagaratnam, J;
Stöhr, W;
Toombs, J;
Heslegrave, A;
Zetterberg, H;
Gisslén, M;
Pett, S;
... RIVER trial study group, .; + view all
(2021)
No evidence of neuronal damage as measured by neurofilament light chain in a HIV cure study utilising a kick-and-kill approach.
Journal of Virus Eradication
, 7
(3)
, Article 100056. 10.1016/j.jve.2021.100056.
|
Alagaratnam, J;
Von Widekind, S;
De Francesco, D;
Underwood, J;
Edison, P;
Winston, A;
Zetterberg, H;
(2021)
Correlation between CSF and blood neurofilament light chain protein: a systematic review and meta-analysis.
BMJ Neurology Open
, 3
(1)
, Article e000143. 10.1136/bmjno-2021-000143.
|
Alawode, Deborah OT;
Heslegrave, Amanda J;
Fox, Nick C;
Zetterberg, Henrik;
(2021)
Donanemab removes Alzheimer's plaques: what is special about its target?
The Lancet Healthy Longevity
, 2
(7)
e395-e396.
10.1016/S2666-7568(21)00144-6.
|
Alawode, DOT;
Heslegrave, AJ;
Ashton, NJ;
Karikari, TK;
Simrén, J;
Montoliu-Gaya, L;
Pannee, J;
... Zetterberg, H; + view all
(2021)
Transitioning from cerebrospinal fluid to blood tests to facilitate diagnosis and disease monitoring in Alzheimer's disease.
Journal of Internal Medicine
, 290
(3)
pp. 583-601.
10.1111/joim.13332.
|
Alcolea, D;
Delaby, C;
Muñoz, L;
Torres, S;
Estellés, T;
Zhu, N;
Barroeta, I;
... Lleó, A; + view all
(2021)
Use of plasma biomarkers for AT(N) classification of neurodegenerative dementias.
Journal of Neurology, Neurosurgery and Psychiatry
10.1136/jnnp-2021-326603.
(In press).
|
Alemany, S;
Crous-Bou, M;
Vilor-Tejedor, N;
Milà-Alomà, M;
Suárez-Calvet, M;
Salvadó, G;
Cirach, M;
... Luis Molinuevo, J; + view all
(2021)
Associations between air pollution and biomarkers of Alzheimer's disease in cognitively unimpaired individuals.
Environment International
, 157
, Article 106864. 10.1016/j.envint.2021.106864.
|
Allison, SL;
Jonaitis, EM;
Koscik, RL;
Hermann, BP;
Mueller, KD;
Cary, RP;
Ma, Y;
... Johnson, SC; + view all
(2021)
Neurodegeneration, Alzheimer's disease biomarkers, and longitudinal verbal learning and memory performance in late middle age.
Neurobiology of Aging
, 102
pp. 151-160.
10.1016/j.neurobiolaging.2021.01.030.
|
Altmann, P;
Ponleitner, M;
Rommer, PS;
Haslacher, H;
Mucher, P;
Leutmezer, F;
Petzold, A;
... Bsteh, G; + view all
(2021)
Seven day pre-analytical stability of serum and plasma neurofilament light chain.
Scientific Reports
, 11
(1)
, Article 11034. 10.1038/s41598-021-90639-z.
|
Andersen, MS;
Bandres-Ciga, S;
Reynolds, RH;
Hardy, J;
Ryten, M;
Krohn, L;
Gan-Or, Z;
... Pihlstrøm, L; + view all
(2021)
Heritability enrichment implicates microglia in Parkinson's disease pathogenesis.
Annals of Neurology
, 89
(5)
pp. 942-951.
10.1002/ana.26032.
|
Anderson, AM;
Kundu, S;
Tang, B;
Vaida, F;
Okwuegbuna, O;
McClernon, D;
Cherner, M;
... Letendre, SL; + view all
(2021)
Cerebrospinal fluid CXCL10 is associated with the presence of low level CSF HIV during suppressive antiretroviral therapy.
Journal of Neuroimmunology
, 353
, Article 577493. 10.1016/j.jneuroim.2021.577493.
|
Andersson, M;
Oras, J;
Thörn, SE;
Karlsson, O;
Kälebo, P;
Zetterberg, H;
Blennow, K;
(2021)
Signs of neuroaxonal injury in preeclampsia-A case control study.
PLoS One
, 16
(2)
, Article e0246786. 10.1371/journal.pone.0246786.
|
Andersson, P;
Johnsson, J;
Björnsson, O;
Cronberg, T;
Hassager, C;
Zetterberg, H;
Stammet, P;
... Frigyesi, A; + view all
(2021)
Predicting neurological outcome after out-of-hospital cardiac arrest with cumulative information; development and internal validation of an artificial neural network algorithm.
Critical Care
, 25
, Article 83. 10.1186/s13054-021-03505-9.
|
Andersson-Hall, U;
Svedin, P;
Mallard, C;
Blennow, K;
Zetterberg, H;
Holmäng, A;
(2021)
Growth differentiation factor 15 increases in both cerebrospinal fluid and serum during pregnancy.
PLoS ONE
, 16
(5)
, Article e0248980. 10.1371/journal.pone.0248980.
|
Andréasson, M;
Lagali, N;
Badian, RA;
Utheim, TP;
Scarpa, F;
Colonna, A;
Allgeier, S;
... Svenningsson, P; + view all
(2021)
Parkinson's disease with restless legs syndrome-an in vivo corneal confocal microscopy study.
npj Parkinsons Disease
, 7
(1)
, Article 4. 10.1038/s41531-020-00148-5.
|
Andreou, D;
Jørgensen, KN;
Nerland, S;
Smelror, RE;
Wedervang-Resell, K;
Johannessen, CH;
Myhre, AM;
... Agartz, I; + view all
(2021)
Lower plasma total tau in adolescent psychosis: Involvement of the orbitofrontal cortex.
Journal of Psychiatric Research
, 144
pp. 255-261.
10.1016/j.jpsychires.2021.10.031.
|
Anesten, B;
Zetterberg, H;
Nilsson, S;
Brew, BJ;
Fuchs, D;
Price, RW;
Gisslén, M;
(2021)
Effect of antiretroviral treatment on blood-brain barrier integrity in HIV-1 infection.
BMC Neurology
, 21
, Article 494. 10.1186/s12883-021-02527-8.
|
Arber, C;
Alatza, A;
Leckey, CA;
Paterson, RW;
Zetterberg, H;
Wray, S;
(2021)
Mass spectrometry analysis of tau and amyloid-beta in iPSC-derived models of Alzheimer's disease and dementia.
Journal of Neurochemistry
10.1111/jnc.15315.
(In press).
|
Arber, C;
Lovejoy, C;
Harris, L;
Willumsen, N;
Alatza, A;
Casey, JM;
Lines, G;
... Wray, S; + view all
(2021)
Familial Alzheimer's Disease Mutations in PSEN1 Lead to Premature Human Stem Cell Neurogenesis.
Cell Reports
, 34
(2)
, Article 108615. 10.1016/j.celrep.2020.108615.
|
Archer, DB;
Moore, EE;
Pamidimukkala, U;
Shashikumar, N;
Pechman, KR;
Blennow, K;
Zetterberg, H;
... Gifford, KA; + view all
(2021)
The relationship between white matter microstructure and self-perceived cognitive decline.
NeuroImage: Clinical
, 32
, Article 102794. 10.1016/j.nicl.2021.102794.
|
Ashton, NJ;
Blennow, K;
Zetterberg, H;
(2021)
Spitting image: can saliva biomarkers reflect Alzheimer's disease?
EBioMedicine
, 68
, Article 103437. 10.1016/j.ebiom.2021.103437.
|
Ashton, NJ;
Janelidze, S;
Al Khleifat, A;
Leuzy, A;
van der Ende, EL;
Karikari, TK;
Benedet, AL;
... Hansson, O; + view all
(2021)
A multicentre validation study of the diagnostic value of plasma neurofilament light.
Nature Communications
, 12
(1)
, Article 3400. 10.1038/s41467-021-23620-z.
|
Ashton, NJ;
Leuzy, A;
Karikari, TK;
Mattsson-Carlgren, N;
Dodich, A;
Boccardi, M;
Corre, J;
... Hansson, O; + view all
(2021)
The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers.
European Journal of Nuclear Medicine and Molecular Imaging
10.1007/s00259-021-05253-y.
(In press).
|
Ashton, NJ;
Pascoal, TA;
Karikari, TK;
Benedet, AL;
Lantero-Rodriguez, J;
Brinkmalm, G;
Snellman, A;
... Blennow, K; + view all
(2021)
Plasma p-tau231: a new biomarker for incipient Alzheimer’s disease pathology.
Acta Neuropathologica
10.1007/s00401-021-02275-6.
(In press).
|
Ashton, NJ;
Suárez-Calvet, M;
Karikari, TK;
Lantero-Rodriguez, J;
Snellman, A;
Sauer, M;
Simrén, J;
... Zetterberg, H; + view all
(2021)
Effects of pre-analytical procedures on blood biomarkers for Alzheimer's pathophysiology, glial activation, and neurodegeneration.
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
, 13
(1)
, Article e12168. 10.1002/dad2.12168.
|
Atilano, ML;
Grönke, S;
Niccoli, T;
Kempthorne, L;
Hahn, O;
Morón-Oset, J;
Hendrich, O;
... Partridge, L; + view all
(2021)
Enhanced insulin signalling ameliorates C9orf72 hexanucleotide repeat expansion toxicity in Drosophila.
eLife
, 10
, Article e58565. 10.7554/eLife.58565.
|
Au, L;
Hatipoglu, E;
Robert de Massy, M;
Litchfield, K;
Beattie, G;
Rowan, A;
Schnidrig, D;
... TRACERx Renal Consortium; + view all
(2021)
Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma.
Cancer Cell
, 39
pp. 1497-1518.
10.1016/j.ccell.2021.10.001.
|
Austin, K;
Lee, BJ;
Flood, TR;
Toombs, J;
Borisova, M;
Lauder, M;
Heslegrave, A;
... Smith, NA; + view all
(2021)
Serum neurofilament light concentration does not increase following exposure to low velocity football heading.
Science and Medicine in Football
, 5
(3)
pp. 188-194.
10.1080/24733938.2020.1853210.
|
B
Backeström, A;
Papadopoulos, K;
Eriksson, S;
Olsson, T;
Andersson, M;
Blennow, K;
Zetterberg, H;
... Rolandsson, O; + view all
(2021)
Acute hyperglycaemia leads to altered frontal lobe brain activity and reduced working memory in type 2 diabetes.
PLOS One
, 16
(3)
, Article e0247753. 10.1371/journal.pone.0247753.
|
Badji, Atef;
Pereira, Joana B;
Shams, Sara;
Skoog, Johan;
Marseglia, Anna;
Poulakis, Konstantinos;
Rydén, Lina;
... Westman, Eric; + view all
(2021)
Cerebrospinal Fluid Biomarkers, Brain Structural and Cognitive Performances Between Normotensive and Hypertensive Controlled, Uncontrolled and Untreated 70-Year-Old Adults.
Frontiers in Aging Neuroscience
, 13
, Article 777475. 10.3389/fnagi.2021.777475.
|
Badodi, S;
Pomella, N;
Zhang, X;
Rosser, G;
Whittingham, J;
Niklison-Chirou, MV;
Lim, YM;
... Marino, S; + view all
(2021)
Inositol treatment inhibits medulloblastoma through suppression of epigenetic-driven metabolic adaptation.
Nature Communications
, 12
(1)
, Article 2148. 10.1038/s41467-021-22379-7.
|
Ball, HA;
McWhirter, L;
Ballard, C;
Bhome, R;
Blackburn, DJ;
Edwards, MJ;
Fox, NC;
... Carson, AJ; + view all
(2021)
Reply: Functional cognitive disorder: dementia's blind spot.
Brain
, 144
(9)
p. 73.
10.1093/brain/awab305.
|
Ballweg, T;
White, M;
Parker, M;
Casey, C;
Bo, A;
Farahbakhsh, Z;
Kayser, A;
... Sanders, RD; + view all
(2021)
Association between plasma tau and postoperative delirium incidence and severity: a prospective observational study.
British Journal of Anaesthesia
, 126
(2)
pp. 458-466.
10.1016/j.bja.2020.08.061.
|
Bampton, A;
Gatt, A;
Humphrey, J;
Cappelli, S;
Bhattacharya, D;
Foti, S;
Brown, A-L;
... Lashley, T; + view all
(2021)
HnRNP K mislocalisation is a novel protein pathology of frontotemporal lobar degeneration and ageing and leads to cryptic splicing.
Acta Neuropathologica
10.1007/s00401-021-02340-0.
(In press).
|
Banerjee, G;
Forsgard, N;
Ambler, G;
Keshavan, A;
Paterson, RW;
Foiani, MS;
Toombs, J;
... Werring, DJ; + view all
(2021)
Cerebrospinal fluid metallomics in cerebral amyloid angiopathy: an exploratory analysis.
Journal of Neurology
10.1007/s00415-021-10711-6.
(In press).
|
Barbier, M;
Camuzat, A;
Hachimi, KE;
Guegan, J;
Rinaldi, D;
Lattante, S;
Houot, M;
... Le Ber, I; + view all
(2021)
SLITRK2, an X-linked modifier of the age at onset in C9orf72 frontotemporal lobar degeneration.
Brain
, 144
(9)
pp. 2798-2811.
10.1093/brain/awab171.
|
Barro, C;
Zetterberg, H;
(2021)
The blood biomarkers puzzle – A review of protein biomarkers in neurodegenerative diseases.
Journal of Neuroscience Methods
, 361
, Article 109281. 10.1016/j.jneumeth.2021.109281.
|
Barro, C;
Zetterberg, H;
(2021)
Neurological symptoms and blood neurofilament light levels.
Acta Neurologica Scandinavica
, 144
(1)
pp. 13-20.
10.1111/ane.13415.
|
Barton, SK;
Gregory, JM;
Selvaraj, BT;
McDade, K;
Henstridge, CM;
Spires-Jones, TL;
James, OG;
... Chandran, S; + view all
(2021)
Dysregulation in Subcellular Localization of Myelin Basic Protein mRNA Does Not Result in Altered Myelination in Amyotrophic Lateral Sclerosis.
Frontiers in Neuroscience
, 15
, Article 705306. 10.3389/fnins.2021.705306.
|
Battista, P;
Griseta, C;
Tortelli, R;
Guida, P;
Castellana, F;
Rivolta, D;
Logroscino, G;
(2021)
The Modified Five-Point Test (MFPT): normative data for a sample of Italian elderly.
Neurological Sciences
, 42
pp. 2431-2440.
10.1007/s10072-020-04818-3.
|
Bayoumy, S;
Verberk, IMW;
den Dulk, B;
Hussainali, Z;
Zwan, M;
van der Flier, WM;
Ashton, NJ;
... Teunissen, CE; + view all
(2021)
Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau231.
Alzheimer’s Research & Therapy
, 13
(1)
, Article 198. 10.1186/s13195-021-00939-9.
|
Behzadi, A;
Pujol-Calderón, F;
Tjust, AE;
Wuolikainen, A;
Höglund, K;
Forsberg, K;
Portelius, E;
... Andersen, PM; + view all
(2021)
Neurofilaments can differentiate ALS subgroups and ALS from common diagnostic mimics.
Scientific Reports
, 11
(1)
, Article 22128. 10.1038/s41598-021-01499-6.
|
Bejanin, A;
Iulita, MF;
Vilaplana, E;
Carmona-Iragui, M;
Benejam, B;
Videla, L;
Barroeta, I;
... Fortea, J; + view all
(2021)
Association of Apolipoprotein E ɛ4 Allele With Clinical and Multimodal Biomarker Changes of Alzheimer Disease in Adults With Down Syndrome.
JAMA Neurology
, 78
(8)
pp. 937-947.
10.1001/jamaneurol.2021.1893.
|
Belloy, ME;
Eger, SJ;
Le Guen, Y;
Napolioni, V;
Deters, KD;
Yang, H-S;
Scelsi, MA;
... Alzheimer's Disease Neuroimaging Initiative; + view all
(2021)
KL∗VS heterozygosity reduces brain amyloid in asymptomatic at-risk APOE∗4 carriers.
Neurobiology of Aging
, 101
pp. 123-129.
10.1016/j.neurobiolaging.2021.01.008.
|
Benedet, AL;
Milà-Alomà, M;
Vrillon, A;
Ashton, NJ;
Pascoal, TA;
Lussier, F;
Karikari, TK;
... Suárez-Calvet, M; + view all
(2021)
Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum.
JAMA Neurology
10.1001/jamaneurol.2021.3671.
(In press).
|
Benhamou, E;
Zhao, S;
Sivasathiaseelan, H;
Johnson, JCS;
Requena-Komuro, M-C;
Bond, RL;
van Leeuwen, JEP;
... Warren, JD; + view all
(2021)
Decoding expectation and surprise in dementia: the paradigm of music.
Brain Communications
, 3
(3)
, Article fcab173. 10.1093/braincomms/fcab173.
|
Benitez, DP;
Jiang, S;
Wood, J;
Wang, R;
Hall, CM;
Peerboom, C;
Wong, N;
... Cummings, DM; + view all
(2021)
Knock-in models related to Alzheimer’s disease: synaptic transmission, plaques and the role of microglia.
Molecular Neurodegeneration
, 16
(1)
, Article 47. 10.1186/s13024-021-00457-0.
|
Benjamin, LA;
Paterson, RW;
Moll, R;
Pericleous, C;
Brown, R;
Mehta, PR;
Athauda, D;
... Efthymiou, M; + view all
(2021)
Antiphospholipid antibodies and neurological manifestations in acute COVID-19: A single-centre cross-sectional study.
EClinicalMedicine
, Article 101070. 10.1016/j.eclinm.2021.101070.
(In press).
|
Benussi, A;
Alberici, A;
Samra, K;
Russell, LL;
Greaves, CV;
Bocchetta, M;
Ducharme, S;
... Borroni, B; + view all
(2021)
Conceptual framework for the definition of preclinical and prodromal frontotemporal dementia.
Alzheimer's & Dementia
10.1002/alz.12485.
(In press).
|
Benussi, A;
Ashton, NJ;
Karikari, TK;
Alberici, A;
Saraceno, C;
Ghidoni, R;
Benussi, L;
... Borroni, B; + view all
(2021)
Prodromal frontotemporal dementia: clinical features and predictors of progression.
Alzheimer's Research and Therapy
, 13
(1)
, Article 188. 10.1186/s13195-021-00932-2.
|
Benussi, A;
Premi, E;
Gazzina, S;
Brattini, C;
Bonomi, E;
Alberici, A;
Jiskoot, L;
... Genetic FTD Initiative (GENFI); + view all
(2021)
Progression of Behavioral Disturbances and Neuropsychiatric Symptoms in Patients With Genetic Frontotemporal Dementia.
JAMA Network Open
, 4
(1)
, Article e2030194. 10.1001/jamanetworkopen.2020.30194.
|
Bergman, L;
Hastie, R;
Zetterberg, H;
Blennow, K;
Schell, S;
Langenegger, E;
Moodley, A;
... Cluver, C; + view all
(2021)
Evidence of neuroinflammation and blood–brain barrier disruption in women with preeclampsia and eclampsia.
Cells
, 10
(11)
, Article 3045. 10.3390/cells10113045.
|
Bergström, P;
Trybala, E;
Eriksson, CE;
Johansson, M;
Satir, TM;
Widéhn, S;
Fruhwürth, S;
... Bergström, T; + view all
(2021)
Herpes Simplex Virus 1 and 2 Infections during Differentiation of Human Cortical Neurons.
Viruses
, 13
(10)
, Article 2072. 10.3390/v13102072.
|
Bergstrom, S;
Oijerstedt, L;
Remnestal, J;
Olofsson, J;
Ullgren, A;
Seelaar, H;
van Swieten, JC;
... Nilsson, P; + view all
(2021)
A panel of CSF proteins separates genetic frontotemporal dementia from presymptomatic mutation carriers: a GENFI study.
Molecular Neurodegeneration
, 16
(1)
, Article 79. 10.1186/s13024-021-00499-4.
|
Bergström, S;
Remnestål, J;
Yousef, J;
Olofsson, J;
Markaki, I;
Carvalho, S;
Corvol, J-C;
... Nilsson, P; + view all
(2021)
Multi-cohort profiling reveals elevated CSF levels of brain-enriched proteins in Alzheimer's disease.
Annals of Clinical and Translational Neurology
, 8
(7)
pp. 1456-1470.
10.1002/acn3.51402.
|
Bettencourt, C;
Miki, Y;
Piras, IS;
de Silva, R;
Foti, SC;
Talboom, JS;
Revesz, T;
... Holton, JL; + view all
(2021)
MOBP and HIP1 in multiple system atrophy: new α‐synuclein partners in glial cytoplasmic inclusions implicated in the disease pathogenesis.
Neuropathology and Applied Neurobiology
, 47
(5)
pp. 640-652.
10.1111/nan.12688.
|
Bhome, R;
Huntley, J;
Dalton-Locke, C;
San Juan, NV;
Oram, S;
Foye, U;
Livingston, G;
(2021)
Impact of the COVID-19 pandemic on older adults mental health services: A mixed methods study.
International Journal of Geriatric Psychiatry
, 36
(11)
pp. 1748-1758.
10.1002/gps.5596.
|
Bjursten, S;
Pandita, A;
Zhao, Z;
Fröjd, C;
Ny, L;
Jensen, C;
Ullerstam, T;
... Levin, M; + view all
(2021)
Early rise in brain damage markers and high ICOS expression in CD4+ and CD8+ T cells during checkpoint inhibitor-induced encephalomyelitis.
Journal for ImmunoTherapy of Cancer
, 9
(7)
10.1136/jitc-2021-002732.
|
Blackstone, C;
Elwood, F;
Plun-Favreau, H;
Lewis, PA;
(2021)
Vesicle trafficking and pathways to neurodegeneration.
Molecular Neurodegeneration
, 16
(1)
, Article 56. 10.1186/s13024-021-00480-1.
|
Blauwendraat, C;
Iwaki, H;
Makarious, MB;
Bandres-Ciga, S;
Leonard, H;
Grenn, FP;
Lake, J;
... Lynch, TL; + view all
(2021)
Investigation of Autosomal Genetic Sex Differences in Parkinson's disease.
Annals of Neurology
, 90
(1)
pp. 35-42.
10.1002/ana.26090.
|
Blomqvist, M;
Zetterberg, H;
Blennow, K;
Månsson, J-E;
(2021)
Sulfatide in health and disease. The evaluation of sulfatide in cerebrospinal fluid as a possible biomarker for neurodegeneration.
Molecular and Cellular Neuroscience
, 116
, Article 103670. 10.1016/j.mcn.2021.103670.
|
Bocchetta, Martina;
Malpetti, Maura;
Todd, Emily G;
Rowe, James B;
Rohrer, Jonathan D;
(2021)
Looking beneath the surface: the importance of subcortical structures in frontotemporal dementia.
Brain Communications
, 3
(3)
, Article fcab158. 10.1093/braincomms/fcab158.
|
Bocchetta, M;
Todd, EG;
Peakman, G;
Cash, DM;
Convery, RS;
Russell, LL;
Thomas, DL;
... Rohrer, JD; + view all
(2021)
Differential early subcortical involvement in genetic FTD within the GENFI cohort.
NeuroImage: Clinical
, Article 102646. 10.1016/j.nicl.2021.102646.
(In press).
|
Bocci, M;
Oudenaarden, C;
Sàenz‐sardà, X;
Simrén, J;
Edén, A;
Sjölund, J;
Möller, C;
... Pietras, K; + view all
(2021)
Infection of brain pericytes underlying neuropathology of covid‐19 patients.
International Journal of Molecular Sciences
, 22
(21)
, Article 11622. 10.3390/ijms222111622.
|
Bondulich, MK;
Fan, Y;
Song, Y;
Giorgini, F;
Bates, GP;
(2021)
Ablation of kynurenine 3-monooxygenase rescues plasma inflammatory cytokine levels in the R6/2 mouse model of Huntington's disease.
Scientific Reports
, 11
(1)
, Article 5484. 10.1038/s41598-021-84858-7.
|
Borrego-Écija, S;
Sala-Llonch, R;
van Swieten, J;
Borroni, B;
Moreno, F;
Masellis, M;
Tartaglia, C;
... Genetic FTD Initiative GENFI; + view all
(2021)
Disease-related cortical thinning in presymptomatic granulin mutation carriers.
NeuroImage: Clinical
, 29
, Article 102540. 10.1016/j.nicl.2020.102540.
|
Bourne, P;
Camic, PM;
Crutch, SJ;
(2021)
Psychosocial outcomes of dyadic arts interventions for people with a dementia and their informal caregivers: A systematic review.
Health & Social Care in the Community
, 29
(6)
pp. 1632-1649.
10.1111/hsc.13267.
|
Brandner, S;
McAleenan, A;
Kelly, C;
Spiga, F;
Cheng, H-Y;
Dawson, S;
Schmidt, L;
... Kurian, KM; + view all
(2021)
MGMT promoter methylation testing to predict overall survival in people with glioblastoma treated with temozolomide: a comprehensive meta-analysis based on a Cochrane Systematic Review.
Neuro-Oncology
, 23
(9)
pp. 1457-1469.
10.1093/neuonc/noab105.
|
Brandner, S;
(2021)
Molecular Diagnostics of Adult Gliomas in Neuropathological Practice.
Acta Medica Academica
, 50
(1)
pp. 29-46.
10.5644/ama2006-124.324.
|
Breuer, W;
Brandner, S;
Hafner-Marx, A;
(2021)
Microcystic Cerebral Neoplasm in a Nilgai Antelope (Boselaphus tragocamelus): Putative Microcystic Meningioma.
Journal of Comparative Pathology
, 186
pp. 69-72.
10.1016/j.jcpa.2021.05.007.
|
Brinkmalm, G;
Zetterberg, H;
(2021)
The phosphorylation cascade hypothesis of Alzheimer’s disease.
Nature Aging
, 1
(6)
pp. 498-499.
10.1038/s43587-021-00077-9.
|
Brockmann, K;
Quadalti, C;
Lerche, S;
Rossi, M;
Wurster, I;
Baiardi, S;
Roeben, B;
... Parchi, P; + view all
(2021)
Association between CSF alpha-synuclein seeding activity and genetic status in Parkinson’s disease and dementia with Lewy bodies.
Acta Neuropathologica Communications
, 9
, Article 175. 10.1186/s40478-021-01276-6.
|
Brogueira Rodrigues, F;
Duarte, G;
Castelao, M;
Marques, R;
Ferreira, J;
Sampaio, C;
Moore, P;
(2021)
Botulinum toxin type A versus anticholinergics for cervical dystonia.
Cochrane Database of Systematic Reviews
(4)
, Article CD004312. 10.1002/14651858.CD004312.pub3.
|
Brogueira Rodrigues, F;
Byrne, L;
Lowe, A;
Tortelli, R;
Heins, M;
Flik, G;
Johnson, E;
... Wild, E; + view all
(2021)
Kynurenine pathway metabolites in cerebrospinal fluid and blood as potential biomarkers in Huntington’s disease.
Journal of Neurochemistry
10.1111/jnc.15360.
(In press).
|
Brooks, LJ;
Clements, MP;
Burden, JJ;
Kocher, D;
Richards, L;
Devesa, SC;
Zakka, L;
... Parrinello, S; + view all
(2021)
The white matter is a pro-differentiative niche for glioblastoma.
Nature Communications
, 12
, Article 2184. 10.1038/s41467-021-22225-w.
|
Brugulat-Serrat, A;
Cañas, A;
Canals, L;
Marne, P;
Gramunt, N;
Milà-Alomà, M;
Suárez-Calvet, M;
... ALFA study; + view all
(2021)
Enhancing the Sensitivity of Memory Tests: Reference Data for the Free and Cued Selective Reminding Test and the Logical Memory Task from Cognitively Healthy Subjects with Normal Alzheimer's Disease Cerebrospinal Fluid Biomarker Levels.
Journal of Alzheimer's Disease
10.3233/JAD-210640.
(In press).
|
Bruno, D;
Plaska, CR;
Clark, DPA;
Zetterberg, H;
Blennow, K;
Verbeek, MM;
Pomara, N;
(2021)
CSF α-synuclein correlates with CSF neurogranin in late-life depression.
International Journal of Neuroscience
, 131
(4)
pp. 357-361.
10.1080/00207454.2020.1744596.
|
Buchanan, SM;
Richards, M;
Schott, JM;
Schrag, A;
(2021)
Mild Parkinsonian Signs: A Systematic Review of Clinical, Imaging, and Pathological Associations.
Movement Disorders
10.1002/mds.28777.
(In press).
|
C
Camporesi, E;
Lashley, T;
Gobom, J;
Lantero-Rodriguez, J;
Hansson, O;
Zetterberg, H;
Blennow, K;
(2021)
Neuroligin-1 in brain and CSF of neurodegenerative disorders: investigation for synaptic biomarkers.
Acta Neuropathologica Communications
, 9
, Article 19. 10.1186/s40478-021-01119-4.
|
Caron, N;
Banos, R;
Yanick, C;
Aly, A;
Byrne, L;
Smith, E;
Xie, Y;
... Southwell, A; + view all
(2021)
Mutant Huntingtin Is Cleared from the Brain via Active Mechanisms in Huntington Disease.
Journal of Neuroscience
, 41
(4)
pp. 780-796.
10.1523/JNEUROSCI.1865-20.2020.
|
Carter, TJ;
Agliardi, G;
Lin, F-Y;
Ellis, M;
Jones, C;
Robson, M;
Richard-Londt, A;
... Chester, K; + view all
(2021)
Potential of Magnetic Hyperthermia to Stimulate Localized Immune Activation.
Small
, Article e2005241. 10.1002/smll.202005241.
(In press).
|
Casaletto, KB;
Zetterberg, H;
Blennow, K;
Brinkmalm, A;
Honer, W;
Schneider, JA;
Bennett, DA;
... Kramer, J; + view all
(2021)
Tripartite Relationship Among Synaptic, Amyloid, and Tau Proteins: An In Vivo and Postmortem Study.
Neurology
, 97
(3)
e284-e297.
10.1212/WNL.0000000000012145.
|
Chan, CK;
Sieber, FE;
Blennow, K;
Inouye, SK;
Kahn, G;
Leoutsakos, J-MS;
Marcantonio, ER;
... Oh, ES; + view all
(2021)
Association of Depressive Symptoms With Postoperative Delirium and CSF Biomarkers for Alzheimer's Disease Among Hip Fracture Patients.
American Journal of Geriatric Psychiatry
, 29
(12)
pp. 1212-1221.
10.1016/j.jagp.2021.02.001.
|
Chatterjee, P;
Pedrini, S;
Stoops, E;
Goozee, K;
Villemagne, VL;
Asih, PR;
Verberk, IMW;
... Martins, RN; + view all
(2021)
Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer's disease.
Translational Psychiatry
, 11
(1)
, Article 27. 10.1038/s41398-020-01137-1.
|
Chebli, J;
Rahmati, M;
Lashley, T;
Edeman, B;
Oldfors, A;
Zetterberg, H;
Abramsson, A;
(2021)
The localization of amyloid precursor protein to ependymal cilia in vertebrates and its role in ciliogenesis and brain development in zebrafish.
Scientific Reports
, 11
, Article 19115. 10.1038/s41598-021-98487-7.
|
Chelban, V;
Breza, M;
Szaruga, M;
Vandrovcova, J;
Murphy, D;
Lee, C-J;
Alikhwan, S;
... Koutsis, G; + view all
(2021)
Spastic paraplegia preceding PSEN1-related familial Alzheimer's disease.
Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring
, 13
(1)
, Article e12186. 10.1002/dad2.12186.
|
Chen, CD;
Joseph-Mathurin, N;
Sinha, N;
Zhou, A;
Li, Y;
Friedrichsen, K;
McCullough, A;
... Benzinger, TLS; + view all
(2021)
Comparing amyloid-β plaque burden with antemortem PiB PET in autosomal dominant and late-onset Alzheimer disease.
Acta Neuropathologica
, 142
pp. 689-706.
10.1007/s00401-021-02342-y.
|
Chen, S-D;
Lu, J-Y;
Li, H-Q;
Yang, Y-X;
Jiang, J-H;
Cui, M;
Zuo, C-T;
... Alzheimer’s Disease Neuroimaging Initiative; + view all
(2021)
Staging tau pathology with tau PET in Alzheimer's disease: a longitudinal study.
Translational Psychiatry
, 11
, Article 483. 10.1038/s41398-021-01602-5.
|
Chen, Z;
Maroofian, R;
Başak, AN;
Shingavi, L;
Karakaya, M;
Efthymiou, S;
Gustavsson, EK;
... Sarraf, P; + view all
(2021)
Novel variants broaden the phenotypic spectrum of PLEKHG5-associated neuropathies.
European Journal of Neurology
, 28
(4)
pp. 1344-1355.
10.1111/ene.14649.
|
Chen, Z;
Zhang, D;
Reynolds, RH;
Gustavsson, EK;
García-Ruiz, S;
D'Sa, K;
Fairbrother-Browne, A;
... Ryten, M; + view all
(2021)
Human-lineage-specific genomic elements are associated with neurodegenerative disease and APOE transcript usage.
Nature Communications
, 12
, Article 2076. 10.1038/s41467-021-22262-5.
|
Chia, R;
Sabir, MS;
Bandres-Ciga, S;
Saez-Atienzar, S;
Reynolds, RH;
Gustavsson, E;
Walton, RL;
... Scholz, SW; + view all
(2021)
Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture.
Nature Genetics
, 53
pp. 294-30353.
10.1038/s41588-021-00785-3.
|
Chiu, M-J;
Yang, S-Y;
Chen, T-F;
Lin, C-H;
Yang, F-C;
Chen, W-P;
Zetterberg, H;
(2021)
Synergistic Association between Plasma Aβ1-42 and p-tau in Alzheimer's Disease but Not in Parkinson's Disease or Frontotemporal Dementia.
ACS Chemical Neuroscience
10.1021/acschemneuro.1c00010.
(In press).
|
Chong, JR;
Ashton, NJ;
Karikari, TK;
Tanaka, T;
Saridin, FN;
Reilhac, A;
Robins, EG;
... Chen, CP; + view all
(2021)
Plasma P‐tau181 to Aβ42 ratio is associated with brain amyloid burden and hippocampal atrophy in an Asian cohort of Alzheimer's disease patients with concomitant cerebrovascular disease.
Alzheimer's & Dementia
, 17
(10)
pp. 1649-1662.
10.1002/alz.12332.
|
Chong, JR;
Ashton, NJ;
Karikari, TK;
Tanaka, T;
Scholl, M;
Zetterberg, H;
Blennow, K;
... Lai, MKP; + view all
(2021)
Blood-based high sensitivity measurements of beta-amyloid and phosphorylated tau as biomarkers of Alzheimer's disease: a focused review on recent advances.
Journal of Neurology, Neurosurgery and Psychiatry
, 92
(11)
pp. 1231-1241.
10.1136/jnnp-2021-327370.
|
Cicognola, C;
Hansson, O;
Scheltens, P;
Kvartsberg, H;
Zetterberg, H;
Teunissen, CE;
Blennow, K;
(2021)
Cerebrospinal fluid N-224 tau helps discriminate Alzheimer's disease from subjective cognitive decline and other dementias.
Alzheimer's Research & Therapy
, 13
(1)
, Article 38. 10.1186/s13195-020-00756-6.
|
Cicognola, C;
Janelidze, S;
Hertze, J;
Zetterberg, H;
Blennow, K;
Mattsson-Carlgren, N;
Hansson, O;
(2021)
Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment.
Alzheimer's Research & Therapy
, 13
, Article 68. 10.1186/s13195-021-00804-9.
|
Ciria, LF;
Suárez-Pinilla, M;
Williams, AG;
Jagannathan, SR;
Sanabria, D;
Bekinschtein, TA;
(2021)
Different underlying mechanisms for high and low arousal in probabilistic learning in humans.
Cortex
, 143
pp. 180-194.
10.1016/j.cortex.2021.07.002.
|
Ciria, LF;
Suarez Pinilla, M;
Williams, AG;
Jagannathan, SR;
Sanabria, D;
Bekinschtein, TA;
(2021)
Different underlying mechanisms for high and low arousal in probabilistic learning in humans.
Cold Spring Harbor Laboratory
|
Clark, C;
Lewczuk, P;
Kornhuber, J;
Richiardi, J;
Maréchal, B;
Karikari, TK;
Blennow, K;
... Popp, J; + view all
(2021)
Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer's disease pathology and clinical disease progression.
Alzheimer's Research & Therapy
, 13
, Article 65. 10.1186/s13195-021-00805-8.
|
Clarke, GJB;
Skandsen, T;
Zetterberg, H;
Einarsen, CE;
Feyling, C;
Follestad, T;
Vik, A;
... Håberg, AK; + view all
(2021)
One-Year Prospective Study of Plasma Biomarkers From CNS in Patients With Mild Traumatic Brain Injury.
Frontiers in Neurology
, 12
, Article 643743. 10.3389/fneur.2021.643743.
|
Clarke, MTM;
St-Onge, F;
Beauregard, J-M;
Bocchetta, M;
Todd, E;
Cash, DM;
Rohrer, JD;
(2021)
Early anterior cingulate involvement is seen in presymptomatic MAPT P301L mutation carriers.
Alzheimers Res Alzheimer's Research & Therapy
, 13
(1)
, Article 42. 10.1186/s13195-021-00777-9.
|
Climaco Pinto, R;
Karaman, I;
Lewis, MR;
Hällqvist, J;
Kaluarachchi, M;
Graça, G;
Chekmeneva, E;
... Ebbels, T; + view all
(2021)
Finding Correspondence between Metabolomic Features in Untargeted Liquid Chromatography-Mass Spectrometry Metabolomics Datasets.
Analytical Chemistry
, 94
(14)
pp. 5493-5503.
10.1021/acs.analchem.1c03592.
|
Convery, RS;
Russell, LL;
Bocchetta, M;
Rohrer, JD;
(2021)
Early detection of frontotemporal dementia (EDoF): A digital biomarker study.
Presented at: Technology and Dementia Preconference, United States.
|
Cope, TE;
Weil, RS;
Düzel, E;
Dickerson, BC;
Rowe, JB;
(2021)
Advances in neuroimaging to support translational medicine in dementia.
Journal of Neurology, Neurosurgery and Psychiatry
, 92
(3)
pp. 263-270.
10.1136/jnnp-2019-322402.
|
Cosker, K;
Mallach, A;
Limaye, J;
Piers, TM;
Staddon, J;
Neame, SJ;
Hardy, J;
(2021)
Microglial signalling pathway deficits associated with the patient derived R47H TREM2 variants linked to AD indicate inability to activate inflammasome.
Scientific Reports
, 11
(1)
, Article 13316. 10.1038/s41598-021-91207-1.
|
Costello, H;
Berry, AJ;
Reeves, S;
Weil, RS;
Joyce, EM;
Howard, R;
Roiser, JP;
(2021)
Disrupted reward processing in Parkinson's disease and its relationship with dopamine state and neuropsychiatric syndromes: a systematic review and meta-analysis.
Journal of Neurology, Neurosurgery & Psychiatry
10.1136/jnnp-2021-327762.
(In press).
|
Cousins, KAQ;
Phillips, JS;
Irwin, DJ;
Lee, EB;
Wolk, DA;
Shaw, LM;
Zetterberg, H;
... Grossman, M; + view all
(2021)
ATN incorporating cerebrospinal fluid neurofilament light chain detects frontotemporal lobar degeneration.
Alzheimer's & Dementia
, 17
(5)
pp. 822-830.
10.1002/alz.12233.
|
Csincsik, L;
Quinn, N;
Yong, KXX;
Crutch, SJ;
Peto, T;
Lengyel, I;
(2021)
Retinal phenotyping of variants of Alzheimer's disease using ultra-widefield retinal images.
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
, 13
(1)
, Article e12232. 10.1002/dad2.12232.
|
Cullen, NC;
Leuzy, A;
Palmqvist, S;
Janelidze, S;
Stomrud, E;
Pesini, P;
Sarasa, L;
... Hansson, O; + view all
(2021)
Individualized prognosis of cognitive decline and dementia in mild cognitive impairment based on plasma biomarker combinations.
Nature Aging
, 1
pp. 114-123.
10.1038/s43587-020-00003-5.
|
Cummings, J;
Schwartz, GG;
Nicholls, SJ;
Khan, A;
Halliday, C;
Toth, PP;
Sweeney, M;
... Ray, KK; + view all
(2021)
Cognitive Effects of the BET Protein Inhibitor Apabetalone: A Prespecified Montreal Cognitive Assessment Analysis Nested in the BETonMACE Randomized Controlled Trial.
Journal of Alzheimer's Disease
10.3233/JAD-210570.
(In press).
|
Cunningham, JL;
Virhammar, J;
Rönnberg, B;
Castro Dopico, X;
Kolstad, L;
Albinsson, B;
Kumlien, E;
... Rostami, E; + view all
(2021)
Anti-SARS-CoV2 antibody responses in serum and cerebrospinal fluid of COVID-19 patients with neurological symptoms.
The Journal of Infectious Diseases
10.1093/infdis/jiab153.
(In press).
|
D
Dams-O'Connor, K;
Bellgowan, PSF;
Corriveau, R;
Pugh, MJ;
Smith, DH;
Schneider, JA;
Whittaker, K;
(2021)
Alzheimer's Disease-Related Dementias Summit 2019: National research priorities for the investigation of traumatic brain injury as a risk factor for Alzheimer's Disease and Related Dementias.
Journal of Neurotrauma
, 38
(23)
pp. 3186-3194.
10.1089/neu.2021.0216.
|
Daniel Lai, LL;
Crutch, SJ;
West, J;
Harding, E;
Brotherhood, EV;
Takhar, R;
Firth, N;
(2021)
Development of the Video Analysis Scale of Engagement (VASE) for people with advanced dementia [version 2; peer review: 2 approved with reservations].
Wellcome Open Research
, 5
, Article 230. 10.12688/wellcomeopenres.16189.2.
|
Daniel Lai, LL;
Crutch, SJ;
West, J;
Harding, E;
Brotherhood, EV;
Takhar, R;
Firth, N;
(2021)
Development of the Video Analysis Scale of Engagement (VASE) for people with advanced dementia [version 3; peer review: 1 approved, 1 approved with reservations].
Wellcome Open Research
, 5
, Article 230. 10.12688/wellcomeopenres.16189.3.
|
Dansson, HV;
Stempfle, L;
Egilsdóttir, H;
Schliep, A;
Portelius, E;
Blennow, K;
Zetterberg, H;
(2021)
Predicting progression and cognitive decline in amyloid-positive patients with Alzheimer’s disease.
Alzheimer's Research and Therapy
, 13
, Article 151. 10.1186/s13195-021-00886-5.
|
Das, SR;
Lyu, X;
Duong, MT;
Xie, L;
McCollum, L;
de Flores, R;
DiCalogero, M;
... Alzheimer's Disease Neuroimaging Initiative; + view all
(2021)
Tau-Atrophy Variability Reveals Phenotypic Heterogeneity in Alzheimer's Disease.
Annals of Neurology
, 90
(5)
pp. 751-762.
10.1002/ana.26233.
|
Day, BL;
Ocal, D;
Peters, A;
Bancroft, MJ;
Cash, D;
Kaski, D;
Crutch, SJ;
(2021)
Altered visual and haptic verticality perception in posterior cortical atrophy and Alzheimer's disease.
The Journal of Physiology
10.1113/JP282289.
(In press).
|
de Rojas, I;
Moreno-Grau, S;
Tesi, N;
Grenier-Boley, B;
Andrade, V;
Jansen, IE;
Pedersen, NL;
... Ruiz, A; + view all
(2021)
Common variants in Alzheimer's disease and risk stratification by polygenic risk scores.
Nature Communications
, 12
(1)
, Article 3417. 10.1038/s41467-021-22491-8.
|
De Rossi, P;
Lewis, AJ;
Furrer, J;
De Vos, L;
Demeter, T;
Zbinden, A;
Zhong, W;
... Polymenidou, M; + view all
(2021)
FTLD-TDP assemblies seed neoaggregates with subtype-specific features via a prion-like cascade.
EMBO Reports
, Article e53877. 10.15252/embr.202153877.
(In press).
|
Dehghanian, Fariba;
Alavi, Shahryar;
(2021)
Molecular mechanisms of the anti-cancer drug, LY2874455, in overcoming the FGFR4 mutation-based resistance.
Scientific Reports
, 11
, Article 16593. 10.1038/s41598-021-96159-0.
|
Delaby, C;
Teunissen, CE;
Blennow, K;
Alcolea, D;
Arisi, I;
Amar, EB;
Beaume, A;
... Lehmann, S; + view all
(2021)
Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview.
Alzheimer's & Dementia
10.1002/alz.12545.
(In press).
|
Delgado-Saborit, JM;
Guercio, V;
Gowers, AM;
Shaddick, G;
Fox, NC;
Love, S;
(2021)
A critical review of the epidemiological evidence of effects of air pollution on dementia, cognitive function and cognitive decline in adult population.
Science of The Total Environment
, 757
, Article 143734. 10.1016/j.scitotenv.2020.143734.
|
Dercon, Q;
Nicholas, JM;
James, SN;
Schott, JM;
Richards, M;
(2021)
Grip strength from midlife as an indicator of later-life brain health and cognition: evidence from a British birth cohort.
BMC Geriatrics
, 21
, Article 475. 10.1186/s12877-021-02411-7.
|
Dewan, R;
Chia, R;
Ding, J;
Hickman, RA;
Stein, TD;
Abramzon, Y;
Ahmed, S;
... Traynor, BJ; + view all
(2021)
Pathogenic Huntingtin Repeat Expansions in Patients with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis.
Neuron
, 109
(3)
448-460.e4.
10.1016/j.neuron.2020.11.005.
|
Di Lazzaro, G;
Magrinelli, F;
Estevez-Fraga, C;
Valente, EM;
Pisani, A;
Bhatia, KP;
(2021)
X-Linked Parkinsonism: Phenotypic and Genetic Heterogeneity.
Movement Disorders
10.1002/mds.28565.
(In press).
|
Díaz Méndez, AB;
Tremante, E;
Regazzo, G;
Brandner, S;
Rizzo, MG;
(2021)
Time to focus on circulating nucleic acids for diagnosis and monitoring of gliomas: a systematic review of their role as biomarkers.
Neuropathology and Applied Neurobiology
, 47
(4)
pp. 471-487.
10.1111/nan.12691.
|
Diaz-Lucena, D;
Kruse, N;
Thüne, K;
Schmitz, M;
Villar-Piqué, A;
da Cunha, JEG;
Hermann, P;
... Llorens, F; + view all
(2021)
TREM2 expression in the brain and biological fluids in prion diseases.
Acta Neuropathologica
10.1007/s00401-021-02296-1.
(In press).
|
Donaldson, Jasmine;
Powell, Sophie;
Rickards, Nadia;
Holmans, Peter;
Jones, Lesley;
(2021)
What is the Pathogenic CAG Expansion Length in Huntington’s Disease?
Journal of Huntington's Disease
, 10
(1)
pp. 175-202.
10.3233/jhd-200445.
|
Dong, R;
Darst, BF;
Deming, Y;
Ma, Y;
Lu, Q;
Zetterberg, H;
Blennow, K;
... Engelman, CD; + view all
(2021)
CSF metabolites associate with CSF tau and improve prediction of Alzheimer's disease status.
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
, 13
, Article e12167. 10.1002/dad2.12167.
|
Driscoll, I;
Ma, Y;
Gallagher, CL;
Johnson, SC;
Asthana, S;
Hermann, BP;
Sager, MA;
... Okonkwo, OC; + view all
(2021)
Age-Related Tau Burden and Cognitive Deficits Are Attenuated in KLOTHO KL-VS Heterozygotes.
Journal of Alzheimer's Disease
, 79
(3)
pp. 1297-1305.
10.3233/JAD-200944.
|
E
Edén, A;
Kanberg, N;
Gostner, J;
Fuchs, D;
Hagberg, L;
Andersson, L-M;
Lindh, M;
... Gisslén, M; + view all
(2021)
CSF Biomarkers in Patients With COVID-19 and Neurologic Symptoms: A Case Series.
Neurology
, 96
(2)
e294-e300.
10.1212/WNL.0000000000010977.
|
Edén, A;
Simrén, J;
Price, RW;
Zetterberg, H;
Gisslén, M;
(2021)
Neurochemical biomarkers to study CNS effects of COVID-19: a narrative review and synthesis.
Journal of Neurochemistry
, 159
(1)
pp. 61-77.
10.1111/jnc.15459.
|
El-Wahsh, S;
Finger, EC;
Piguet, O;
Mok, V;
Rohrer, JD;
Kiernan, MC;
Ahmed, RM;
(2021)
Predictors of survival in frontotemporal lobar degeneration syndromes.
Journal of Neurology, Neurosurgery & Psychiatry
, 92
(4)
pp. 425-433.
10.1136/jnnp-2020-324349.
|
Ennis, GE;
Koscik, RL;
Ma, Y;
Jonaitis, EM;
Van Hulle, CA;
Betthauser, TJ;
Randall, AM;
... Bendlin, BB; + view all
(2021)
Insulin resistance is related to cognitive decline but not change in CSF biomarkers of Alzheimer's disease in non-demented adults.
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
, 13
(1)
, Article e12220. 10.1002/dad2.12220.
|
Eratne, D;
Janelidze, S;
Malpas, CB;
Loi, S;
Walterfane, M;
Merritt, A;
Diouf, I;
... Santillo, A; + view all
(2021)
Plasma neurofilament light chain protein is not increased in treatment-resistant schizophrenia and first-degree relatives.
Australian and New Zealand Journal of Psychiatry
10.1177/00048674211058684.
(In press).
|
Eriksson, H;
Banote, RK;
Larsson, D;
Blennow, K;
Zetterberg, H;
Zelano, J;
(2021)
Brain injury markers in new-onset seizures in adults: A pilot study.
Seizure
, 92
pp. 62-67.
10.1016/j.seizure.2021.08.012.
|
Esteras, N;
Kopach, O;
Maiolino, M;
Lariccia, V;
Amoroso, S;
Qamar, S;
Wray, S;
... Abramov, AY; + view all
(2021)
Mitochondrial ROS control neuronal excitability and cell fate in frontotemporal dementia.
Alzheimer's Dementia
10.1002/alz.12394.
(In press).
|
Estevez-Fraga, C;
Magrinelli, F;
Hensman Moss, D;
Mulroy, E;
Di Lazzaro, G;
Latorre, A;
Mackenzie, M;
... Bhatia, KP; + view all
(2021)
Expanding the Spectrum of Movement Disorders Associated With C9orf72 Hexanucleotide Expansions.
Neurology Genetics
, 7
(2)
e575-e575.
10.1212/nxg.0000000000000575.
|
Estevez-Fraga, C;
Scahill, RI;
Durr, A;
Leavitt, BR;
Roos, RAC;
Langbehn, DR;
Rees, G;
... Tabrizi, SJ; + view all
(2021)
Composite UHDRS Correlates With Progression of Imaging Biomarkers in Huntington's Disease.
Movement Disorders
10.1002/mds.28489.
(In press).
|
Ewers, M;
Luan, Y;
Frontzkowski, L;
Neitzel, J;
Rubinski, A;
Dichgans, M;
Hassenstab, J;
... Alzheimer’s Disease Neuroimaging Initiative and the Dominantly I; + view all
(2021)
Segregation of functional networks is associated with cognitive resilience in Alzheimer's disease.
Brain
, 144
(7)
pp. 2176-2185.
10.1093/brain/awab112.
|
F
Fairbrother-Browne, A;
Ali, AT;
Reynolds, RH;
Garcia-Ruiz, S;
Zhang, D;
Chen, Z;
Ryten, M;
(2021)
Mitochondrial-nuclear cross-talk in the human brain is modulated by cell type and perturbed in neurodegenerative disease.
Communications Biology
, 4
(1)
, Article 1262. 10.1038/s42003-021-02792-w.
|
Fällmar, D;
Rostami, E;
Kumlien, E;
Ashton, NJ;
Jackmann, S;
Pavel, R;
Blennow, K;
... Virhammar, J; + view all
(2021)
The extent of neuroradiological findings in COVID-19 shows correlation with blood biomarkers, Glasgow coma scale score and days in intensive care.
Journal of Neuroradiology
10.1016/j.neurad.2021.11.003.
(In press).
|
Fatima, T;
Jacobsson, LTH;
Kern, S;
Zettergren, A;
Blennow, K;
Zetterberg, H;
Johansson, L;
... Skoog, I; + view all
(2021)
Association between serum urate and CSF markers of Alzheimer's disease pathology in a population-based sample of 70-year-olds.
Alzheimers Dementia
, 13
(1)
, Article e12241. 10.1002/dad2.12241.
|
Feleke, R;
Reynolds, RH;
Smith, AM;
Tilley, B;
Taliun, SAG;
Hardy, J;
Matthews, PM;
... Ryten, M; + view all
(2021)
Cross-platform transcriptional profiling identifies common and distinct molecular pathologies in Lewy body diseases.
Acta Neuropathologica
10.1007/s00401-021-02343-x.
(In press).
|
Fernández-Abascal, B;
Suárez-Pinilla, P;
Cobo-Corrales, C;
Crespo-Facorro, B;
Suarez-Pinilla, M;
(2021)
In- and outpatient lifestyle interventions on diet and exercise and their effect on physical and psychological health: a systematic review and meta-analysis of randomised controlled trials in patients with schizophrenia spectrum disorders and first episode of psychosis.
Neuroscience & Biobehavioral Reviews
, 125
pp. 535-568.
10.1016/j.neubiorev.2021.01.005.
|
Ferreira, JJ;
Brogueira Rodrigues, F;
Duarte, GS;
Mestre, TA;
Bachoud-Levi, AC;
Bentivoglio, AR;
Burgunder, JM;
... Sampaio, C; + view all
(2021)
A MDS Evidence-Based Review on Treatments for Huntington's Disease.
Movement Disorders
10.1002/mds.28855.
(In press).
|
Fiford, CM;
Sudre, CH;
Young, AL;
Macdougall, A;
Nicholas, J;
Manning, EN;
Malone, IB;
... Alzheimer’s Disease Neuroimaging Initiative, .; + view all
(2021)
Presumed small vessel disease, imaging and cognition markers in the Alzheimer's Disease Neuroimaging Initiative.
Brain Communications
, 3
(4)
, Article fcab226. 10.1093/braincomms/fcab226.
|
Forsberg, M;
Olsson, M;
Seth, H;
Wasling, P;
Zetterberg, H;
Hedner, J;
Hanse, E;
(2021)
Ion concentrations in cerebrospinal fluid in wakefulness, sleep and sleep deprivation in healthy humans.
Journal of Sleep Research
10.1111/jsr.13522.
(In press).
|
Franklin, HD;
Russell, LL;
Peakman, G;
Greaves, CV;
Bocchetta, M;
Nicholas, J;
Poos, J;
... Genetic FTD Initiative, GENFI, .; + view all
(2021)
The Revised Self-Monitoring Scale detects early impairment of social cognition in genetic frontotemporal dementia within the GENFI cohort.
Alzheimer's Research & Therapy
, 13
(1)
, Article 127. 10.1186/s13195-021-00865-w.
|
Frithiof, R;
Rostami, E;
Kumlien, E;
Virhammar, J;
Fällmar, D;
Hultström, M;
Lipcsey, M;
... Punga, AR; + view all
(2021)
Critical illness polyneuropathy, myopathy and neuronal biomarkers in COVID-19 patients: A prospective study.
Clinical Neurophysiology
10.1016/j.clinph.2021.03.016.
(In press).
|
G
Gabriele, Rebecca Maria Cecilia;
(2021)
Investigating the function of the Alzheimer’s disease risk gene BIN1 and its role in Alzheimer’s disease.
Doctoral thesis (Ph.D), UCL (University College London).
|
Gaetani, L;
Bellomo, G;
Parnetti, L;
Blennow, K;
Zetterberg, H;
Di Filippo, M;
(2021)
Neuroinflammation and Alzheimer's Disease: A Machine Learning Approach to CSF Proteomics.
Cells
, 10
(8)
, Article 1930. 10.3390/cells10081930.
|
Gallo, V;
McElvenny, DM;
Seghezzo, G;
Kemp, S;
Williamson, E;
Lu, K;
Mian, S;
... Pearce, N; + view all
(2021)
Concussion and long-term cognitive function among rugby players-The BRAIN Study.
Alzheimer's & Dementia
10.1002/alz.12455.
(In press).
|
Gang, Q;
Bettencourt, C;
Brady, S;
Holton, JL;
Healy, EG;
McConville, J;
Morrison, PJ;
... Houlden, H; + view all
(2021)
Genetic defects are common in myopathies with tubular aggregates.
Annals of Clinical and Translational Neurology
10.1002/acn3.51477.
(In press).
|
Gangoso, E;
Southgate, B;
Bradley, L;
Rus, S;
Galvez-Cancino, F;
McGivern, N;
Güç, E;
... Pollard, SM; + view all
(2021)
Glioblastomas acquire myeloid-affiliated transcriptional programs via epigenetic immunoediting to elicit immune evasion.
Cell
10.1016/j.cell.2021.03.023.
(In press).
|
García-Ayllón, M-S;
Moreno-Pérez, O;
García-Arriaza, J;
Ramos-Rincón, J-M;
Cortés-Gómez, M-Á;
Brinkmalm, G;
Andrés, M;
... Sáez-Valero, J; + view all
(2021)
Plasma ACE2 species are differentially altered in COVID-19 patients.
FASEB Journal
, 35
(8)
, Article e21745. 10.1096/fj.202100051R.
|
García-Ruiz, S;
Gil-Martínez, AL;
Cisterna, A;
Jurado-Ruiz, F;
Reynolds, RH;
NABEC (North America Brain Expression Consortium), .;
Cookson, MR;
... Botía, JA; + view all
(2021)
CoExp: A Web Tool for the Exploitation of Co-expression Networks.
Frontiers in Gentics
, 12
, Article 630187. 10.3389/fgene.2021.630187.
|
Garland, P;
Morton, M;
Zolnourian, A;
Durnford, A;
Gaastra, B;
Toombs, J;
Heslegrave, AJ;
... Galea, I; + view all
(2021)
Neurofilament light predicts neurological outcome after subarachnoid haemorrhage.
Brain
10.1093/brain/awaa451.
(In press).
|
Gillard, S;
Dare, C;
Hardy, J;
Nyikavaranda, P;
Rowan Olive, R;
Shah, P;
Birken, M;
... NIHR Mental Health Policy Research Unit Covid coproduction resea; + view all
(2021)
Experiences of living with mental health problems during the COVID-19 pandemic in the UK: a coproduced, participatory qualitative interview study.
Social Psychiatry and Psychiatric Epidemiology
, 56
pp. 1447-1457.
10.1007/s00127-021-02051-7.
|
Giovannelli, I;
Bayatti, N;
Brown, A;
Wang, D;
Mickunas, M;
Camu, W;
Veyrune, J-L;
... Kirby, J; + view all
(2021)
Amyotrophic lateral sclerosis transcriptomics reveals immunological effects of low-dose interleukin-2.
Brain Communications
, 3
(3)
, Article fcab141. 10.1093/braincomms/fcab141.
(In press).
|
Gisslen, M;
Keating, SM;
Spudich, S;
Arechiga, V;
Stephenson, S;
Zetterberg, H;
Di Germanio, C;
... Price, RW; + view all
(2021)
Compartmentalization of cerebrospinal fluid inflammation across the spectrum of untreated HIV-1 infection, central nervous system injury and viral suppression.
PLoS One
, 16
(5)
, Article e0250987. 10.1371/journal.pone.0250987.
|
Gkanatsiou, E;
Nilsson, J;
Toomey, CE;
Vrillon, A;
Kvartsberg, H;
Portelius, E;
Zetterberg, H;
... Brinkmalm, G; + view all
(2021)
Amyloid pathology and synaptic loss in pathological aging.
Journal of Neurochemistry
10.1111/jnc.15487.
(In press).
|
Gkanatsiou, E;
Sahlin, C;
Portelius, E;
Johannesson, M;
Söderberg, L;
Fälting, J;
Basun, H;
... Brinkmalm, G; + view all
(2021)
Characterization of monomeric and soluble aggregated Aβ in Down's syndrome and Alzheimer's disease brains.
Neuroscience Letters
, 754
, Article 135894. 10.1016/j.neulet.2021.135894.
|
Gleason, CE;
Zuelsdorff, M;
Gooding, DC;
Kind, AJH;
Johnson, AL;
James, TT;
Lambrou, NH;
... Zetterberg, H; + view all
(2021)
Alzheimer's disease biomarkers in Black and non-Hispanic White cohorts: A contextualized review of the evidence.
Alzheimer's & Dementia
10.1002/alz.12511.
(In press).
|
Gleerup, HS;
Sanna, F;
Hogh, P;
Simren, J;
Blennow, K;
Zetterberg, H;
Hasselbalch, SG;
... Simonsen, AH; + view all
(2021)
Saliva Neurofilament Light Chain Is Not a Diagnostic Biomarker for Neurodegeneration in a Mixed Memory Clinic Population.
Frontiers in Aging Neuroscience
, 13
, Article 659898. 10.3389/fnagi.2021.659898.
|
Gobom, J;
Parnetti, L;
Rosa-Neto, P;
Vyhnalek, M;
Gauthier, S;
Cataldi, S;
Lerch, O;
... Blennow, K; + view all
(2021)
Validation of the LUMIPULSE automated immunoassay for the measurement of core AD biomarkers in cerebrospinal fluid.
Clinical Chemistry and Laboratory Medicine
10.1515/cclm-2021-0651.
(In press).
|
Gomez-Paredes, C;
Mason, MA;
Taxy, BA;
Papadopoulou, AS;
Paganetti, P;
Bates, GP;
(2021)
The heat shock response, determined by QuantiGene multiplex, is impaired in HD mouse models and not caused by HSF1 reduction.
Scientific Reports
, 11
, Article 9117. 10.1038/s41598-021-88715-5.
|
Gonneaud, J;
Baria, AT;
Pichet Binette, A;
Gordon, BA;
Chhatwal, JP;
Cruchaga, C;
Jucker, M;
... Carter, R; + view all
(2021)
Accelerated functional brain aging in pre-clinical familial Alzheimer’s disease.
Nature Communications
, 12
(1)
, Article 5346. 10.1038/s41467-021-25492-9.
|
Gonzalez, Maria C;
Ashton, Nicholas J;
Gomes, Bárbara Fernandes;
Tovar-Rios, Diego Alejandro;
Blanc, Frédéric;
Karikari, Thomas K;
Mollenhauer, Brit;
... European–Dementia With Lewy Bodies (E-DLB) Consortium, .; + view all
(2021)
Association of Plasma p-tau181 and p-tau231 Concentrations With Cognitive Decline in Patients With Probable Dementia With Lewy Bodies.
JAMA Neurology
, 79
(1)
pp. 32-37.
10.1001/jamaneurol.2021.4222.
|
Goold, R;
Hamilton, J;
Menneteau, T;
Flower, M;
Bunting, EL;
Aldous, SG;
Porro, A;
... Tabrizi, SJ; + view all
(2021)
FAN1 controls mismatch repair complex assembly via MLH1 retention to stabilize CAG repeat expansion in Huntington's disease.
Cell Reports
, 36
(9)
, Article 109649. 10.1016/j.celrep.2021.109649.
|
Gordon, E;
Bocchetta, M;
Nicholas, J;
Cash, DM;
Rohrer, JD;
(2021)
A comparison of automated atrophy measures across the frontotemporal dementia spectrum: Implications for trials.
NeuroImage: Clinical
, 32
, Article 102842. 10.1016/j.nicl.2021.102842.
|
Goteson, A;
Isgren, A;
Jonsson, L;
Sparding, T;
Smedler, E;
Pelanis, A;
Zetterberg, H;
... Landen, M; + view all
(2021)
Cerebrospinal fluid proteomics targeted for central nervous system processes in bipolar disorder.
Molecular Psychiatry
, 26
pp. 7446-7453.
10.1038/s41380-021-01236-5.
|
Graff-Radford, J;
Yong, KXX;
Apostolova, LG;
Bouwman, FH;
Carrillo, M;
Dickerson, BC;
Rabinovici, GD;
... Murray, ME; + view all
(2021)
New insights into atypical Alzheimer's disease in the era of biomarkers.
The Lancet Neurology
, 20
(3)
pp. 222-234.
10.1016/S1474-4422(20)30440-3.
|
Graham, NSN;
Zimmerman, KA;
Moro, F;
Heslegrave, A;
Maillard, SA;
Bernini, A;
Miroz, J-P;
... Sharp, DJ; + view all
(2021)
Axonal marker neurofilament light predicts long-term outcomes and progressive neurodegeneration after traumatic brain injury.
Science Translational Medicine
, 13
(613)
, Article eabg9922. 10.1126/scitranslmed.abg9922.
|
Grau-Rivera, O;
Navalpotro-Gomez, I;
Sánchez-Benavides, G;
Suárez-Calvet, M;
Milà-Alomà, M;
Arenaza-Urquijo, EM;
Salvadó, G;
... ALFA Study; + view all
(2021)
Association of weight change with cerebrospinal fluid biomarkers and amyloid positron emission tomography in preclinical Alzheimer's disease.
Alzheimer's Research & Therapy
, 13
, Article 46. 10.1186/s13195-021-00781-z.
|
Griffin, BA;
Booth, MS;
Busse, M;
Wild, EJ;
Setodji, C;
Warner, JH;
Sampaio, C;
(2021)
Estimating the causal effects of modifiable, non-genetic factors on Huntington disease progression using propensity score weighting.
Parkinsonism & Related Disorders
, 83
pp. 56-62.
10.1016/j.parkreldis.2021.01.010.
|
Groothuis, I;
Sudre, CH;
Ingala, S;
Barnes, J;
Gispert, JD;
Sørensen, L;
Pai, A;
... Modat, M; + view all
(2021)
Lesion-wise evaluation for effective performance monitoring of small object segmentation.
In:
Proceedings SPIE 11596, Medical Imaging 2021: Image Processing.
SPIE
|
Grothe, MJ;
Moscoso, A;
Ashton, NJ;
Karikari, TK;
Lantero-Rodriguez, J;
Snellman, A;
Zetterberg, H;
... Alzheimer’s Disease Neuroimaging Initiative; + view all
(2021)
Associations of Fully Automated CSF and Novel Plasma Biomarkers With Alzheimer Disease Neuropathology at Autopsy.
Neurology
10.1212/WNL.0000000000012513.
(In press).
|
Guzmán-Vélez, E;
Zetterberg, H;
Fox-Fuller, JT;
Vila-Castelar, C;
Sanchez, JS;
Baena, A;
Garcia-Ospina, G;
... Quiroz, YT; + view all
(2021)
Associations between plasma neurofilament light, in vivo brain pathology, and cognition in non-demented individuals with autosomal-dominant Alzheimer's disease.
Alzheimer's & Dementia
, 17
(5)
pp. 813-821.
10.1002/alz.12248.
|
H
Halaas, NB;
Zetterberg, H;
Idland, A-V;
Knapskog, A-B;
Watne, LO;
Blennow, K;
(2021)
Cerebrospinal Fluid Concentration of Neurogranin in Hip Fracture Patients with Delirium.
Journal of Alzheimer's Disease
10.3233/JAD-201341.
(In press).
|
Hallén, T;
Olsson, DS;
Hammarstrand, C;
Farahmand, D;
Olofsson, AC;
Jakobsson Ung, E;
Jakobsson, S;
... Skoglund, T; + view all
(2021)
Circulating brain injury biomarkers increase after endoscopic surgery for pituitary tumors.
Journal of Clinical Neuroscience
, 89
pp. 113-121.
10.1016/j.jocn.2021.04.030.
|
Hampel, H;
Hardy, J;
Blennow, K;
Chen, C;
Perry, G;
Kim, SH;
Villemagne, VL;
... Vergallo, A; + view all
(2021)
The Amyloid-beta Pathway in Alzheimer's Disease.
Molecular Psychiatry
10.1038/s41380-021-01249-0.
(In press).
|
Hannaway, N;
Lao-Kaim, NP;
Martín-Bastida, A;
Roussakis, A-A;
Howard, J;
Wall, MB;
Loane, C;
... Piccini, P; + view all
(2021)
Longitudinal changes in movement-related functional MRI activity in Parkinson's disease patients.
Parkinsonism & Related Disorders
, 87
pp. 61-69.
10.1016/j.parkreldis.2021.04.025.
|
Hansson, O;
Batrla, R;
Brix, B;
Carrillo, MC;
Corradini, V;
Edelmayer, RM;
Esquivel, RN;
... Blennow, K; + view all
(2021)
The Alzheimer's Association international guidelines for handling of cerebrospinal fluid for routine clinical measurements of amyloid β and tau.
Alzheimer's & Dementia
, 17
(9)
pp. 1575-1582.
10.1002/alz.12316.
|
Harding, Emma;
Robinson, Philip;
Wilson, James;
Crutch, Sebastian J;
Mummery, Catherine J;
(2021)
Injections of hope: supporting participants in clinical trials.
BMJ
, 375
, Article e066851. 10.1136/bmj-2021-066851.
|
Hardy, J;
Salih, D;
(2021)
TREM2-mediated activation of microglia breaks link between amyloid and tau.
The Lancet Neurology
, 20
(6)
pp. 416-417.
10.1016/s1474-4422(21)00133-2.
|
Haugg, A;
Renz, FM;
Nicholson, AA;
Lor, C;
Götzendorfer, SJ;
Sladky, R;
Skouras, S;
... Steyrl, D; + view all
(2021)
Predictors of real-time fMRI neurofeedback performance and improvement-A machine learning mega-analysis.
NeuroImage
, 237
, Article 118207. 10.1016/j.neuroimage.2021.118207.
|
Hay, M;
Ryan, L;
Huentelman, M;
Konhilas, J;
Hoyer-Kimura, C;
Beach, TG;
Serrano, GE;
... Parthasarathy, S; + view all
(2021)
Serum Neurofilament Light is elevated in COVID-19 Positive Adults in the ICU and is associated with Co-Morbid Cardiovascular Disease, Neurological Complications, and Acuity of Illness.
Cardiology and Cardiovascular Medicine
, 5
(5)
pp. 551-565.
10.26502/fccm.92920221.
|
Henter, J-I;
Kvedaraite, E;
Martin Munoz, D;
Cheng Munthe-Kaas, M;
Zeller, B;
Nystad, TA;
Bjorklund, C;
... von Bahr Greenwood, T; + view all
(2021)
Response to mitogen-activated protein kinase inhibition of neurodegeneration in Langerhans cell histiocytosis monitored by cerebrospinal fluid neurofilament light as a biomarker: a pilot study.
British Journal of Haematology
10.1111/bjh.17781.
(In press).
|
Hill, E;
Karikari, TK;
Lantero-Rodriguez, J;
Zetterberg, H;
Blennow, K;
Richardson, MJ;
Wall, MJ;
(2021)
Truncating tau reveals different pathophysiological actions of oligomers in single neurons.
Communications Biology
, 4
, Article 1265. 10.1038/s42003-021-02791-x.
|
Holloway, C;
Bhot, W;
Yong, K;
McCarthy, I;
Suzuki, T;
Carton, A;
Yang, B;
... CHO, Y; + view all
(2021)
STEP-UP: Enabling low-cost IMU sensors to predict the type of dementia during everyday stair climbing.
Frontiers in Computer Science
10.3389/fcomp.2021.804917.
(In press).
|
Holmegaard, L;
Stanne, TM;
Andreasson, U;
Zetterberg, H;
Blennow, K;
Blomstrand, C;
Jood, K;
(2021)
Proinflammatory Protein Signatures in Cryptogenic and Large Artery Atherosclerosis Stroke.
Acta Neurologica Scandinavica
, 143
(3)
pp. 303-312.
10.1111/ane.13366.
|
Holmes, E;
Utoomprurkporn, N;
Hoskote, C;
Warren, JD;
Bamiou, D-E;
Griffiths, TD;
(2021)
Simultaneous auditory agnosia: Systematic description of a new type of auditory segregation deficit following a right hemisphere lesion.
Cortex
, 135
pp. 92-107.
10.1016/j.cortex.2020.10.023.
|
Hong, S;
Dobricic, V;
Ohlei, O;
Bos, I;
Vos, SJB;
Prokopenko, D;
Tijms, BM;
... Bertram, L; + view all
(2021)
TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer's disease biomarker levels.
Alzheimer's & Dementia
, 17
(10)
pp. 1628-1640.
10.1002/alz.12330.
|
Howard, R;
Schott, J;
(2021)
When dementia is misdiagnosed.
International Journal of Geriatric Psychiatry
, 36
(6)
pp. 799-801.
10.1002/gps.5538.
|
Hung, C;
Tuck, E;
Stubbs, V;
Van der Lee, SJ;
Aalfs, C;
Van Spaendonk, R;
Scheltens, P;
... Livesey, FJ; + view all
(2021)
SORL1 deficiency in human excitatory neurons causes APP-dependent defects in the endolysosome-autophagy network.
Cell Reports
, 35
(11)
, Article 109259. 10.1016/j.celrep.2021.109259.
|
I
Illán-Gala, I;
Lleo, A;
Karydas, A;
Staffaroni, AM;
Zetterberg, H;
Sivasankaran, R;
Grinberg, LT;
... Rojas, JC; + view all
(2021)
Plasma Tau and Neurofilament Light in Frontotemporal Lobar Degeneration and Alzheimer Disease.
Neurology
, 96
(5)
e671-e683.
10.1212/WNL.0000000000011226.
|
Ingala, S;
De Boer, C;
Masselink, LA;
Vergari, I;
Lorenzini, L;
Blennow, K;
Chételat, G;
... EPAD consortium; + view all
(2021)
Application of the ATN classification scheme in a population without dementia: Findings from the EPAD cohort.
Alzheimer's & Dementia
, 17
(7)
pp. 1189-1204.
10.1002/alz.12292.
|
Innes, JA;
Lowe, AS;
Fonseca, R;
Aley, N;
El-Hassan, T;
Constantinou, M;
Lau, J;
... Brandner, S; + view all
(2021)
Phenotyping clonal populations of glioma stem cell reveals a high degree of plasticity in response to changes of microenvironment.
Laboratory Investigation
10.1038/s41374-021-00695-2.
(In press).
|
Iwan, Katharina;
Patel, Nina;
Heslegrave, Amanda;
Borisova, Mina;
Lee, Laura;
Bower, Rebecca;
Mole, Sara E;
... Heywood, Wendy E; + view all
(2021)
Cerebrospinal fluid neurofilament light chain levels in CLN2 disease patients treated with enzyme replacement therapy normalise after two years on treatment.
F1000Research
, 10
, Article 614. 10.12688/f1000research.54556.2.
|
Iwan, K;
Patel, N;
Heslegrave, A;
Borisova, M;
Lee, L;
Bower, R;
Mole, SE;
... Heywood, WE; + view all
(2021)
Cerebrospinal fluid neurofilament light levels in CLN2 disease patients treated with enzyme replacement therapy normalise after two years on treatment [version 1; peer review: 1 approved with reservations].
F1000Research
, 10
, Article 614. 10.12688/f1000research.54556.1.
|
Izzo, NJ;
Yuede, CM;
LaBarbera, KM;
Limegrover, CS;
Rehak, C;
Yurko, R;
Waybright, L;
... Catalano, SM; + view all
(2021)
Preclinical and clinical biomarker studies of CT1812: A novel approach to Alzheimer's disease modification.
Alzheimer's & Dementia
10.1002/alz.12302.
|
J
Jabbari, E;
Koga, S;
Valentino, R;
Reynolds, R;
Ferrari, R;
Tan, M;
Rowe, J;
... Morris, H; + view all
(2021)
Genetic determinants of survival in progressive supranuclear palsy: a genome-wide association study.
The Lancet Neurology
, 20
(2)
pp. 107-116.
10.1016/S1474-4422(20)30394-X.
|
James, S-N;
Nicholas, JM;
Lane, CA;
Parker, TD;
Lu, K;
Keshavan, A;
Buchanan, SM;
... Fox, NC; + view all
(2021)
A population‐based study of head injury, cognitive function and pathological markers.
Annals of Clinical and Translational Neurology
10.1002/acn3.51331.
(In press).
|
Janelidze, S;
Teunissen, CE;
Zetterberg, H;
Allué, JA;
Sarasa, L;
Eichenlaub, U;
Bittner, T;
... Hansson, O; + view all
(2021)
Head-to-Head Comparison of 8 Plasma Amyloid-β 42/40 Assays in Alzheimer Disease.
JAMA Neurology
10.1001/jamaneurol.2021.3180.
(In press).
|
Jaunmuktane, Z;
Banerjee, G;
Paine, S;
Parry-Jones, A;
Rudge, P;
Grieve, J;
Toma, AK;
... Brandner, S; + view all
(2021)
Alzheimer's disease neuropathological change three decades after iatrogenic amyloid-β transmission.
Acta Neuropathologica
10.1007/s00401-021-02326-y.
(In press).
|
Jeon, Y-H;
Shin, M;
Smith, A;
Beattie, E;
Brodaty, H;
Frost, D;
Hobbs, A;
... Waters, D; + view all
(2021)
Early Implementation and Evaluation of StepUp for Dementia Research: An Australia-Wide Dementia Research Participation and Public Engagement Platform.
International Journal of Environmental Research and Public Health
, 18
(21)
, Article 11353. 10.3390/ijerph182111353.
|
Jiang, W;
Luo, Z;
Stephenson, S;
Li, H;
Di Germanio, C;
Norris, PJ;
Fuchs, D;
... Price, RW; + view all
(2021)
Cerebrospinal fluid and plasma lipopolysaccharide (LPS) levels in HIV-1 infection and associations with inflammation, blood-brain barrier permeability and neuronal injury.
Journal of Infectious Diseases
, 223
(9)
pp. 1612-1620.
10.1093/infdis/jiaa765.
|
Jiang, J;
Benhamou, E;
Waters, S;
Johnson, JCS;
Volkmer, A;
Weil, RS;
Marshall, CR;
... Hardy, CJD; + view all
(2021)
Processing of Degraded Speech in Brain Disorders.
Brain Sciences
, 11
(3)
10.3390/brainsci11030394.
|
Johnson, JO;
Chia, R;
Miller, DE;
Li, R;
Kumaran, R;
Abramzon, Y;
Alahmady, N;
... Turner, MR; + view all
(2021)
Association of Variants in the SPTLC1 Gene with Juvenile Amyotrophic Lateral Sclerosis.
JAMA Neurology
10.1001/jamaneurol.2021.2598.
|
Johnson, EB;
Parker, CS;
Scahill, RI;
Gregory, S;
Papoutsi, M;
Zeun, P;
Osborne-Crowley, K;
... HD-YAS Investigators; + view all
(2021)
Altered iron and myelin in premanifest Huntington's Disease more than 20 years before clinical onset: Evidence from the cross-sectional HD Young Adult Study.
EBioMedicine
, 65
, Article 103266. 10.1016/j.ebiom.2021.103266.
|
Johnson, JCS;
McWhirter, L;
Hardy, CJD;
Crutch, SJ;
Marshall, CR;
Mummery, CJ;
Rohrer, JD;
... Warren, JD; + view all
(2021)
Suspecting dementia: canaries, chameleons and zebras.
Practical Neurology
10.1136/practneurol-2021-003019.
(In press).
|
Johnson, M;
Fernell, E;
Gillberg, C;
Fasth, A;
Dinkler, L;
Blennow, K;
Zetterberg, H;
(2021)
No neurochemical evidence of neuronal injury or glial activation in children with Pediatric Acute-onset Neuropsychiatric Syndrome: An explorative pilot study.
The World Journal of Biological Psychiatry
10.1080/15622975.2021.1907716.
(In press).
|
Joseph-Mathurin, N;
Wang, G;
Kantarci, K;
Jack, CR;
McDade, E;
Hassenstab, J;
Blazey, TM;
... Dominantly Inherited Alzheimer Network; + view all
(2021)
Longitudinal Accumulation of Cerebral Microhemorrhages in Dominantly Inherited Alzheimer Disease.
Neurology
10.1212/WNL.0000000000011542.
(In press).
|
K
Kagiava, A;
Karaiskos, C;
Richter, J;
Tryfonos, C;
Jennings, MJ;
Heslegrave, AJ;
Sargiannidou, I;
... Kleopa, KA; + view all
(2021)
AAV9-mediated Schwann cell-targeted gene therapy rescues a model of demyelinating neuropathy.
Gene Therapy
10.1038/s41434-021-00250-0.
(In press).
|
Kaiyrzhanov, R;
Aitkulova, A;
Vandrovcova, J;
Murphy, D;
Zharkinbekova, N;
Shashkin, C;
Akhmetzhanov, V;
... Houlden, H; + view all
(2021)
A glimpse of the genetics of young-onset Parkinson's disease in Central Asia.
Molecular Genetics & Genomic Medicine
10.1002/mgg3.1671.
(In press).
|
Kamer, AR;
Pushalkar, S;
Gulivindala, D;
Butler, T;
Li, Y;
Annam, KRC;
Glodzik, L;
... De Leon, MJ; + view all
(2021)
Periodontal dysbiosis associates with reduced CSF Aβ42 in cognitively normal elderly.
Alzheimer's & Dementia
, 13
(1)
, Article e12172. 10.1002/dad2.12172.
|
Kanberg, N;
Simrén, J;
Edén, A;
Andersson, LM;
Nilsson, S;
Ashton, NJ;
Sundvall, PD;
... Gisslén, M; + view all
(2021)
Neurochemical signs of astrocytic and neuronal injury in acute COVID-19 normalizes during long-term follow-up.
EBioMedicine
, 70
, Article 103512. 10.1016/j.ebiom.2021.103512.
|
Kang, MS;
Shin, M;
Ottoy, J;
Aliaga, AA;
Mathotaarachchi, S;
Quispialaya, K;
Pascoal, TA;
... Rosa-Neto, P; + view all
(2021)
Preclinical in vivo longitudinal assessment of KG207-M as a disease-modifying Alzheimer's disease therapeutic.
Journal of Cerebral Blood Flow & Metabolism
10.1177/0271678X211035625.
(In press).
|
Kara, E;
Crimi, A;
Wiedmer, A;
Emmenegger, M;
Manzoni, C;
Bandres-Ciga, S;
D'Sa, K;
... Aguzzi, A; + view all
(2021)
An integrated genomic approach to dissect the genetic landscape regulating the cell-to-cell transfer of α-synuclein.
Cell Reports
, 35
(10)
, Article 109189. 10.1016/j.celrep.2021.109189.
|
Karikari, TK;
Benedet, AL;
Ashton, NJ;
Lantero Rodriguez, J;
Snellman, A;
Suárez-Calvet, M;
Saha-Chaudhuri, P;
... Alzheimer’s Disease Neuroimaging Initiative; + view all
(2021)
Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer's Disease Neuroimaging Initiative.
Molecular Psychiatry
, 26
pp. 429-442.
10.1038/s41380-020-00923-z.
|
Karikari, TK;
Emeršič, A;
Vrillon, A;
Lantero-Rodriguez, J;
Ashton, NJ;
Kramberger, MG;
Dumurgier, J;
... Blennow, K; + view all
(2021)
Head‐to‐head comparison of clinical performance of CSF phospho‐tau T181 and T217 biomarkers for Alzheimer's disease diagnosis.
Alzheimer's & Dementia
, 17
(5)
pp. 755-767.
10.1002/alz.12236.
|
Keddie, S;
Pakpoor, J;
Mousele, C;
Pipis, M;
Machado, PM;
Foster, M;
Record, CJ;
... Lunn, MP; + view all
(2021)
Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barré syndrome.
Brain
, 144
(2)
pp. 682-693.
10.1093/brain/awaa433.
|
Kehoe, PG;
Turner, N;
Howden, B;
Jarutyt, L;
Clegg, SL;
Malone, IB;
Barnes, J;
... Ben-Shlomo, Y; + view all
(2021)
Losartan to slow the progression of mild-to-moderate Alzheimer's disease through angiotensin targeting: the RADAR RCT.
Efficacy and Mechanism Evaluation
, 8
(19)
pp. 1-72.
10.3310/eme08190.
|
Kehoe, PG;
Turner, N;
Howden, B;
Jarutyte, L;
Clegg, SL;
Malone, IB;
Barnes, J;
... RADAR investigators, .; + view all
(2021)
Safety and efficacy of losartan for the reduction of brain atrophy in clinically diagnosed Alzheimer's disease (the RADAR trial): a double-blind, randomised, placebo-controlled, phase 2 trial.
Lancet Neurology
, 20
(11)
pp. 895-906.
10.1016/S1474-4422(21)00263-5.
|
Keret, O;
Staffaroni, AM;
Ringman, JM;
Cobigo, Y;
Goh, S-YM;
Wolf, A;
Allen, IE;
... Dominantly Inherited Alzheimer Network; + view all
(2021)
Pattern and degree of individual brain atrophy predicts dementia onset in dominantly inherited Alzheimer's disease.
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
, 13
(1)
, Article e12197. 10.1002/dad2.12197.
|
Keshavan, A;
McAnena, L;
Acheson, JF;
Booth, H;
Plant, GT;
Khaleeli, Z;
(2021)
Bilateral optic neuritis as a first presentation of lymph node tuberculosis.
Practical Neurology
10.1136/practneurol-2021-003086.
(In press).
|
Keshavan, A;
Pannee, J;
Karikari, T;
Lantero Rodriguez, J;
Ashton, NJ;
Nicholas, JM;
Cash, D;
... Schott, J; + view all
(2021)
Population-based blood screening for pre-clinical Alzheimer's disease in a British birth cohort at age 70.
Brain
, 144
(2)
pp. 434-449.
10.1093/brain/awaa403.
|
Keshavan, A;
Wellington, H;
Chen, Z;
Khatun, A;
Chapman, M;
Hart, M;
Cash, DM;
... Schott, JM; + view all
(2021)
Concordance of CSF measures of Alzheimer's pathology with amyloid PET status in a preclinical cohort: A comparison of Lumipulse and established immunoassays.
Alzheimer's & Dementia
, 13
(1)
, Article e12131. 10.1002/dad2.12131.
|
Khani, M;
Shamshiri, H;
Taheri, H;
Hardy, J;
Bras, JT;
Carmona, S;
Moazzeni, H;
... Elahi, E; + view all
(2021)
BVVL/ FL: features caused by SLC52A3 mutations; WDFY4 and TNFSF13B may be novel causative genes.
Neurobiology of Aging
, 99
102.e1-102.e10.
10.1016/j.neurobiolaging.2020.09.021.
|
Khani, M;
Taheri, H;
Shamshiri, H;
Moazzeni, H;
Hardy, J;
Bras, JT;
InanlooRahatloo, K;
... Elahi, E; + view all
(2021)
Deep geno- and phenotyping in two consanguineous families with CMT2 reveals HADHA as an unusual disease-causing gene and an intronic variant in GDAP1 as an unusual mutation.
Journal of Neurology
, 268
pp. 640-650.
10.1007/s00415-020-10171-4.
|
Kia, DA;
Zhang, D;
Guelfi, S;
Manzoni, C;
Hubbard, L;
Reynolds, RH;
Botía, J;
... Botiá, JA; + view all
(2021)
Identification of Candidate Parkinson Disease Genes by Integrating Genome-Wide Association Study, Expression, and Epigenetic Data Sets.
JAMA Neurology
, 78
(4)
pp. 464-472.
10.1001/jamaneurol.2020.5257.
|
Kinnunen, KM;
Mullin, AP;
Pustina, D;
Turner, EC;
Burton, J;
Gordon, MF;
Scahill, RI;
... Schwarz, AJ; + view all
(2021)
Recommendations to Optimize the Use of Volumetric MRI in Huntington's Disease Clinical Trials.
Frontiers in Neurology
, 12
, Article 712565. 10.3389/fneur.2021.712565.
|
Kinnunen, KM;
Schwarz, AJ;
Turner, EC;
Pustina, D;
Gantman, EC;
Gordon, MF;
Joules, R;
... Georgiou-Karistianis, N; + view all
(2021)
Volumetric MRI-Based Biomarkers in Huntington's Disease: An Evidentiary Review.
Frontiers in Neurology
, 12
, Article 712555. 10.3389/fneur.2021.712555.
|
Kivimäki, M;
Walker, KA;
Pentti, J;
Nyberg, S;
Mars, N;
Vahtera, J;
Suominen, SB;
... Lindbohm, J; + view all
(2021)
Cognitive stimulation in the workplace, plasma proteins, and risk of dementia: three analyses of population cohort studies.
The British Medical Journal
, 374
, Article n1804. 10.1136/bmj.n1804.
|
Klionsky, DJ;
Abdel-Aziz, AK;
Abdelfatah, S;
Abdellatif, M;
Abdoli, A;
Abel, S;
Abeliovich, H;
... Taylor, A; + view all
(2021)
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition).
Autophagy
, 17
(1)
pp. 1-382.
10.1080/15548627.2020.1797280.
|
Knopman, DS;
Lundt, ES;
Therneau, TM;
Albertson, SM;
Gunter, JL;
Senjem, ML;
Schwarz, CG;
... Alzheimer’s Disease Neuroimaging Initiative; + view all
(2021)
Association of Initial β-Amyloid Levels With Subsequent Flortaucipir Positron Emission Tomography Changes in Persons Without Cognitive Impairment.
JAMA Neurology
, 78
(2)
pp. 217-228.
10.1001/jamaneurol.2020.3921.
|
Kocovski, Pece;
Tabassum-Sheikh, Nuzhat;
Marinis, Stephanie;
Dang, Phuc T;
Hale, Matthew W;
Orian, Jacqueline M;
(2021)
Immunomodulation Eliminates Inflammation in the Hippocampus in Experimental Autoimmune Encephalomyelitis, but Does Not Ameliorate Anxiety-Like Behavior.
Frontiers in Immunology
, 12
, Article 639650. 10.3389/fimmu.2021.639650.
|
Koelsche, C;
Schrimpf, D;
Stichel, D;
Sill, M;
Sahm, F;
Reuss, DE;
Blattner, M;
... von Deimling, A; + view all
(2021)
Sarcoma classification by DNA methylation profiling.
Nature Communications
, 12
, Article 498. 10.1038/s41467-020-20603-4.
|
Koivikko, P;
Posti, JP;
Mohammadian, M;
Lagerstedt, L;
Azurmendi, L;
Hossain, I;
Katila, AJ;
... Takala, RSK; + view all
(2021)
Potential of heart fatty-acid binding protein, neurofilament light, interleukin-10 and S100 calcium-binding protein B in the acute diagnostics and severity assessment of traumatic brain injury.
Emergency Medicine Journal
10.1136/emermed-2020-209471.
(In press).
|
Kopach, O;
Esteras, N;
Wray, S;
Abramov, AY;
Rusakov, DA;
(2021)
Genetically engineered MAPT 10+16 mutation causes pathophysiological excitability of human iPSC-derived neurons related to 4R tau-induced dementia.
Cell Death & Disease
, 12
(8)
, Article 716. 10.1038/s41419-021-04007-w.
|
Koriath, CAM;
Kenny, J;
Ryan, NS;
Rohrer, JD;
Schott, JM;
Houlden, H;
Fox, NC;
... Mead, S; + view all
(2021)
Genetic testing in dementia — utility and clinical strategies.
Nature Reviews Neurology
, 17
pp. 23-36.
10.1038/s41582-020-00416-1.
|
Kotting, P;
Smith, A;
O'Hare, MB;
Giebel, C;
Mendis, L;
Shaw, C;
Shillito, I;
(2021)
A national open-access research registry to improve recruitment to clinical studies.
Alzheimer's & Dementia: Translational Research & Clinical Interventions
, 7
(1)
, Article e12221. 10.1002/trc2.12221.
|
Kumar, A;
Shoai, M;
Palmqvist, S;
Stomrud, E;
Hardy, J;
Mattsson-Carlgren, N;
Hansson, O;
(2021)
Genetic effects on longitudinal cognitive decline during the early stages of Alzheimer's disease.
Scientific Reports
, 11
, Article 19853. 10.1038/s41598-021-99310-z.
|
L
Lalli, G;
Rossor, M;
Rowe, JB;
De Strooper, B;
(2021)
The Dementia UK Ecosystem: a call to action.
The Lancet Neurology
, 20
(9)
pp. 699-700.
10.1016/S1474-4422(21)00246-5.
|
Lalli, G;
Schott, JM;
Hardy, J;
De Strooper, B;
(2021)
Aducanumab: a new phase in therapeutic development for Alzheimer’s disease?
EMBO Molecular Medicine
, 13
, Article e14781. 10.15252/emmm.202114781.
|
Lana-Elola, E;
Cater, H;
Watson-Scales, S;
Greenaway, S;
Müller-Winkler, J;
Gibbins, D;
Nemes, M;
... Tybulewicz, VLJ; + view all
(2021)
Comprehensive phenotypic analysis of the Dp1Tyb mouse strain reveals a broad range of down syndrome-related phenotypes.
Disease Models & Mechanisms
10.1242/dmm.049157.
(In press).
|
Landles, C;
Milton, RE;
Jean, A;
McLarnon, S;
McAteer, SJ;
Taxy, BA;
Osborne, GF;
... Bates, GP; + view all
(2021)
Development of novel bioassays to detect soluble and aggregated Huntingtin proteins on three technology platforms.
Brain Communications
, 3
(1)
, Article fcaa231. 10.1093/braincomms/fcaa231.
|
Lane, CA;
Barnes, J;
Nicholas, JM;
Baker, JW;
Sudre, CH;
Cash, DM;
Parker, TD;
... Schott, JM; + view all
(2021)
Investigating the relationship between BMI across adulthood and late life brain pathologies.
Alzheimer's Research and Therapy
, 13
(1)
, Article 91. 10.1186/s13195-021-00830-7.
|
Lange, J;
Gillham, O;
Alkharji, R;
Eaton, S;
Ferrari, G;
Madej, M;
Flower, M;
... Ferretti, P; + view all
(2021)
Dystrophin deficiency affects human astrocyte properties andresponse to damage.
Glia
10.1002/glia.24116.
(In press).
|
Lange, J;
Wood-Kaczmar, A;
Ali, A;
Farag, S;
Ghosh, R;
Parker, J;
Casey, C;
... Tabrizi, SJ; + view all
(2021)
Mislocalization of Nucleocytoplasmic Transport Proteins in Human Huntington’s Disease PSC-Derived Striatal Neurons.
Frontiers in Cellular Neuroscience
, 15
, Article 742763. 10.3389/fncel.2021.742763.
|
Lantero-Rodriguez, J;
Snellman, A;
Benedet, AL;
Mila-Aloma, M;
Camporesi, E;
Montoliu-Gaya, L;
Ashton, NJ;
... Blennow, K; + view all
(2021)
P-tau235: a novel biomarker for staging preclinical Alzheimer's disease.
EMBO Molecular Medicine
, Article e15098. 10.15252/emmm.202115098.
(In press).
|
Larsen, JR;
Kobborg, T;
Shahim, P;
Blennow, K;
Rasmussen, LS;
Zetterberg, H;
(2021)
Serum-neuroproteins, near-infrared spectroscopy, and cognitive outcome after beach-chair shoulder surgery: observational cohort study analyses.
Acta Anaesthesiologica Scandinavica
, 65
(1)
pp. 26-33.
10.1111/aas.13691.
|
Lashley, T;
Tossounian, M-A;
Costello Heaven, N;
Wallworth, S;
Peak-Chew, S;
Bradshaw, A;
Cooper, JM;
... Gout, I; + view all
(2021)
Extensive Anti-CoA Immunostaining in Alzheimer’s Disease and Covalent Modification of Tau by a Key Cellular Metabolite Coenzyme A.
Frontiers in Cellular Neuroscience
, 15
, Article 739425. 10.3389/fncel.2021.739425.
|
Lasica, AB;
Jaunmuktane, Z;
Fersht, N;
Kirkman, MA;
Dixon, L;
Hoskote, C;
Brandner, S;
(2021)
Genomic Prognosticators and Extent of Resection in Molecularly Subtyped World Health Organization Grade II and III Gliomas–A Single-Institution, Nine-Year Data.
World Neurosurgery
, 151
e217-e233.
10.1016/j.wneu.2021.04.026.
|
Laurikkala, J;
Aneman, A;
Peng, A;
Reinikainen, M;
Pham, P;
Jakkula, P;
Hästbacka, J;
... Skrifvars, MB; + view all
(2021)
Association of deranged cerebrovascular reactivity with brain injury following cardiac arrest: a post-hoc analysis of the COMACARE trial.
Critical Care
, 25
, Article 350. 10.1186/s13054-021-03764-6.
|
Lawingco, T;
Chaudhury, S;
Brookes, KJ;
Guetta-Baranes, T;
Guerreiro, R;
Bras, J;
Hardy, J;
... Morgan, K; + view all
(2021)
Genetic variants in glutamate-, Aβ-, and tau-related pathways determine polygenic risk for Alzheimer's disease.
Neurobiology of Aging
, 101
299.e13-299.e21.
10.1016/j.neurobiolaging.2020.11.009.
|
Lemarquis, A;
Campbell, T;
Aranda-Guillén, M;
Hennings, V;
Brodin, P;
Kämpe, O;
Blennow, K;
... Ekwall, O; + view all
(2021)
Severe COVID-19 in an APS1 patient with interferon autoantibodies treated with plasmapheresis.
Journal of Allergy and Clinical Immunology
10.1016/j.jaci.2021.03.034.
(In press).
|
Lemercier, P;
Vergallo, A;
Lista, S;
Zetterberg, H;
Blennow, K;
Potier, M-C;
Habert, M-O;
... Hampel, H; + view all
(2021)
Association of plasma Aβ40/Aβ42 ratio and brain Aβ accumulation: testing a whole-brain PLS-VIP in individuals at risk of Alzheimer's disease.
Neurobiology of Aging
, 107
pp. 57-69.
10.1016/j.neurobiolaging.2021.07.005.
|
Lerche, S;
Sjoedin, S;
Brinkmalm, A;
Blennow, K;
Wurster, I;
Roeben, B;
Zimmermann, M;
... Brockmann, K; + view all
(2021)
CSF Protein Level of Neurotransmitter Secretion, Synaptic Plasticity, and Autophagy in PD and DLB.
Movement Disorders
10.1002/mds.28704.
(In press).
|
Leuzy, A;
Ashton, NJ;
Mattsson-Carlgren, N;
Dodich, A;
Boccardi, M;
Corre, J;
Drzezga, A;
... Hansson, O; + view all
(2021)
2020 update on the clinical validity of cerebrospinal fluid amyloid, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework.
European Journal of Nuclear Medicine and Molecular Imaging
10.1007/s00259-021-05258-7.
(In press).
|
Licata, N;
Cristofani, R;
Salomonsson, S;
Wilson, KM;
Kempthorne, L;
Vaizoglu, D;
D'Agostino, VG;
... Provenzani, A; + view all
(2021)
C9orf72 ALS/FTD dipeptide repeat protein levels are reduced by small molecules that inhibit PKA or enhance protein degradation.
The EMBO Journal
, Article e105026. 10.15252/embj.2020105026.
(In press).
|
Lindberg, O;
Kern, S;
Skoog, J;
Machado, A;
Pereira, JB;
Sacuiu, SF;
Wahlund, LO;
... Skoog, I; + view all
(2021)
Effects of amyloid pathology and the APOE ε4 allele on the association between cerebrospinal fluid Aβ38 and Aβ40 and brain morphology in cognitively normal 70-years-olds.
Neurobiology of Aging
, 101
pp. 1-12.
10.1016/j.neurobiolaging.2020.10.033.
|
Lindbohm, JV;
Mars, N;
Walker, KA;
Singh-Manoux, A;
Livingston, G;
Brunner, EJ;
Sipilä, PN;
... Kivimäki, M; + view all
(2021)
Plasma proteins, cognitive decline, and 20-year risk of dementia in the Whitehall II and Atherosclerosis Risk in Communities studies.
Alzheimer's and Dementia
10.1002/alz.12419.
(In press).
|
Liu, KY;
Howard, R;
Banerjee, S;
Comas‐Herrera, A;
Goddard, J;
Knapp, M;
Livingston, G;
... Burns, A; + view all
(2021)
Dementia wellbeing and COVID‐19: Review and expert consensus on current research and knowledge gaps.
International Journal of Geriatric Psychiatry
, 36
(11)
pp. 1597-1639.
10.1002/gps.5567.
|
Lleó, A;
Zetterberg, H;
Pegueroles, J;
Karikari, TK;
Carmona-Iragui, M;
Ashton, NJ;
Montal, V;
... Fortea, J; + view all
(2021)
Phosphorylated tau181 in plasma as a potential biomarker for Alzheimer's disease in adults with Down syndrome.
Nature Communications
, 12
, Article 4304. 10.1038/s41467-021-24319-x.
|
Lopes Alves, I;
Heeman, F;
Collij, LE;
Salvadó, G;
Tolboom, N;
Vilor-Tejedor, N;
Markiewicz, P;
... Gispert, JD; + view all
(2021)
Strategies to reduce sample sizes in Alzheimer’s disease primary and secondary prevention trials using longitudinal amyloid PET imaging.
Alzheimer's Research & Therapy
, 13
, Article 82. 10.1186/s13195-021-00819-2.
|
Lord, J;
Zettergren, A;
Ashton, NJ;
Karikari, TK;
Benedet, AL;
Simrén, J;
Hye, A;
... Proitsi, P; + view all
(2021)
A genome-wide association study of plasma phosphorylated tau181.
Neurobiology of Aging
10.1016/j.neurobiolaging.2021.04.018.
(In press).
|
Lu, K;
Nicholas, JM;
Pertzov, Y;
Grogan, J;
Husain, M;
Pavisic, IM;
James, S-N;
... Crutch, SJ; + view all
(2021)
Dissociable effects of APOE ε4 and β-amyloid pathology on visual working memory.
Nature Aging
, 1
pp. 1002-1009.
10.1038/s43587-021-00117-4.
|
Lu, K;
Nicholas, JM;
Weston, PSJ;
Stout, JC;
O’Regan, AM;
James, SN;
Buchanan, SM;
... Crutch, SJ; + view all
(2021)
Visuomotor integration deficits are common to familial and sporadic preclinical Alzheimer's disease.
Brain Communications
, 3
(1)
, Article fcab003. 10.1093/braincomms/fcab003.
|
Luckett, PH;
McCullough, A;
Gordon, BA;
Strain, J;
Flores, S;
Dincer, A;
McCarthy, J;
... Dominantly Inherited Alzheimer Network (DIAN), .; + view all
(2021)
Modeling autosomal dominant Alzheimer's disease with machine learning.
Alzheimer's & Dementia
, 17
(6)
pp. 1005-1016.
10.1002/alz.12259.
|
Lukkarinen, H;
Tesseur, I;
Pemberton, D;
Van Der Ark, P;
Timmers, M;
Slemmon, R;
Janssens, L;
... Leinonen, V; + view all
(2021)
Time Trends of Cerebrospinal Fluid Biomarkers of Neurodegeneration in Idiopathic Normal Pressure Hydrocephalus.
Journal of Alzheimer's Disease
10.3233/JAD-201361.
(In press).
|
Lussier, FZ;
Benedet, AL;
Therriault, J;
Pascoal, TA;
Tissot, C;
Chamoun, M;
Mathotaarachchi, S;
... Alzheimer’s Disease Neuroimaging Initiative; + view all
(2021)
Plasma levels of phosphorylated tau 181 are associated with cerebral metabolic dysfunction in cognitively impaired and amyloid-positive individuals.
Brain Communications
, 3
(2)
, Article fcab073. 10.1093/braincomms/fcab073.
|
Ly, H;
Verma, N;
Sharma, S;
Kotiya, D;
Despa, S;
Abner, EL;
Nelson, PT;
... Despa, F; + view all
(2021)
The association of circulating amylin with β‐amyloid in familial Alzheimer's disease.
Alzheimer's & Dementia
, 7
(1)
, Article e12130. 10.1002/trc2.12130.
|
Lybeck, A;
Friberg, H;
Nielsen, N;
Rundgren, M;
Ullén, S;
Zetterberg, H;
Blennow, K;
... Westhall, E; + view all
(2021)
Postanoxic electrographic status epilepticus and serum biomarkers of brain injury.
Resuscitation
, 158
pp. 253-257.
10.1016/j.resuscitation.2020.10.027.
|
M
Ma, Y;
Norton, DL;
Van Hulle, CA;
Chappell, RJ;
Lazar, KK;
Jonaitis, EM;
Koscik, RL;
... Carlsson, CM; + view all
(2021)
Measurement batch differences and between-batch conversion of Alzheimer's disease cerebrospinal fluid biomarker values.
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
, 13
(1)
, Article e12194. 10.1002/dad2.12194.
|
Maas, SLN;
Stichel, D;
Hielscher, T;
Sievers, P;
Berghoff, AS;
Schrimpf, D;
Sill, M;
... German Consortium on Aggressive Meningiomas (KAM); + view all
(2021)
Integrated Molecular-Morphologic Meningioma Classification: A Multicenter Retrospective Analysis, Retrospectively and Prospectively Validated.
Journal of Clinical Oncology
10.1200/JCO.21.00784.
(In press).
|
Maciver, CL;
Al Busaidi, A;
Ganeshan, B;
Maynard, JA;
Wastling, S;
Hyare, H;
Brandner, S;
... Thust, SC; + view all
(2021)
Filtration‐histogram based magnetic resonance texture analysis (Mrta) for the distinction of primary central nervous system lymphoma and glioblastoma.
Journal of Personalized Medicine
, 11
(9)
, Article 876. 10.3390/jpm11090876.
|
Mackenzie, Strachan;
Shafat, Manar;
Roddy, Harriet;
Hyare, Harpreet;
Neill, Lorna;
Marzolini, Maria AV;
Gilhooley, Michael;
... Roddie, Claire; + view all
(2021)
Pembrolizumab for the treatment of progressive multifocal leukoencephalopathy following anti-CD19 CAR-T therapy: a case report.
EJHaem
, 2
(4)
pp. 848-853.
10.1002/jha2.274.
|
Magrinelli, F;
Mehta, S;
Di Lazzaro, G;
Latorre, A;
Edwards, MJ;
Balint, B;
Basu, P;
... Bhatia, KP; + view all
(2021)
Dissecting the Phenotype and Genotype of PLA2G6-Related Parkinsonism.
Movement Disorders
10.1002/mds.28807.
(In press).
|
Magusali, N;
Graham, AC;
Piers, TM;
Panichnantakul, P;
Yaman, U;
Shoai, M;
Reynolds, RH;
... Salih, DA; + view all
(2021)
A genetic link between risk for Alzheimer's disease and severe COVID-19 outcomes via the OAS1 gene.
Brain
10.1093/brain/awab337.
(In press).
|
Mahoney, CJ;
Ahmed, RM;
Huynh, W;
Tu, S;
Rohrer, JD;
Bedlack, RS;
Hardiman, O;
(2021)
Pathophysiology and Treatment of Non-motor Dysfunction in Amyotrophic Lateral Sclerosis.
CNS Drugs
, 35
(5)
pp. 483-505.
10.1007/s40263-021-00820-1.
|
Mallach, A;
Gobom, J;
Arber, C;
Piers, TM;
Hardy, J;
Wray, S;
Zetterberg, H;
(2021)
Differential stimulation of pluripotent stem cell-derived human microglia leads to exosomal proteomic changes affecting neurons.
Cells
, 10
(11)
, Article 2866. 10.3390/cells10112866.
|
Mallach, A;
Gobom, J;
Zetterberg, H;
Hardy, J;
Piers, TM;
Wray, S;
Pocock, JM;
(2021)
The influence of the R47H triggering receptor expressed on myeloid cells 2 variant on microglial exosome profiles.
Brain Communications
, 3
(2)
, Article fcab009. 10.1093/braincomms/fcab009.
|
Malpetti, M;
Jones, PS;
Tsvetanov, KA;
Rittman, T;
van Swieten, JC;
Borroni, B;
Sanchez-Valle, R;
... Genfi, OBOTGFI; + view all
(2021)
Apathy in presymptomatic genetic frontotemporal dementia predicts cognitive decline and is driven by structural brain changes.
Alzheimer's & Dementia
, 17
(6)
pp. 969-983.
10.1002/alz.12252.
|
Manera, AL;
Dadar, M;
Van Swieten, JC;
Borroni, B;
Sanchez-Valle, R;
Moreno, F;
Laforce, R;
... GENFI Consortium, .; + view all
(2021)
MRI data-driven algorithm for the diagnosis of behavioural variant frontotemporal dementia.
Journal of Neurology, Neurosurgery & Psychiatry
, 92
(6)
pp. 608-616.
10.1136/jnnp-2020-324106.
|
Mansoor, NM;
Vanniyasingam, T;
Malone, I;
Hobbs, NZ;
Rees, E;
Durr, A;
Roos, RAC;
... Scahill, RI; + view all
(2021)
Validating Automated Segmentation Tools in the Assessment of Caudate Atrophy in Huntington’s Disease.
Frontiers in Neurology
, 12
, Article 616272. 10.3389/fneur.2021.616272.
|
Markiewicz, P;
Matthews, JC;
Ashburner, J;
Cash, D;
Thomas, D;
De Vita, E;
Barnes, A;
... Barkhof, F; + view all
(2021)
Uncertainty analysis of MR-PET image registration for precision neuro-PET imaging.
NeuroImage
, 232
, Article 117821. 10.1016/j.neuroimage.2021.117821.
|
Marklund, N;
Vedung, F;
Lubberink, M;
Tegner, Y;
Johansson, J;
Blennow, K;
Zetterberg, H;
... Antoni, G; + view all
(2021)
Tau aggregation and increased neuroinflammation in athletes after sports-related concussions and in traumatic brain injury patients – A PET/MR study.
NeuroImage: Clinical
, 30
, Article 102665. 10.1016/j.nicl.2021.102665.
|
Mason, Michael;
(2021)
Investigating the mechanism of the incomplete splicing of huntingtin in models of Huntington’s disease.
Doctoral thesis (Ph.D), UCL (University College London).
|
Mattila, OS;
Ashton, NJ;
Blennow, K;
Zetterberg, H;
Harve-Rytsälä, H;
Pihlasviita, S;
Ritvonen, J;
... Lindsberg, PJ; + view all
(2021)
Ultra-Early Differential Diagnosis of Acute Cerebral Ischemia and Hemorrhagic Stroke by Measuring the Prehospital Release Rate of GFAP.
Clinical Chemistry
, Article hvab128. 10.1093/clinchem/hvab128.
(In press).
|
McAleenan, A;
Kelly, C;
Spiga, F;
Kernohan, A;
Cheng, H-Y;
Dawson, S;
Schmidt, L;
... Kurian, KM; + view all
(2021)
Prognostic value of test(s) for O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide.
Cochrane Database of Systematic Reviews
, 3
, Article CD013316. 10.1002/14651858.CD013316.pub2.
|
McColgan, P;
Helbling, S;
Vaculciakova, L;
Pine, K;
Wagstyl, K;
Attar, FM;
Edwards, L;
... Weiskopf, N; + view all
(2021)
Relating quantitative 7T MRI across cortical depths to cytoarchitectonics, gene expression and connectomics.
HUMAN BRAIN MAPPING
, 42
(15)
pp. 4996-5009.
10.1002/hbm.25595.
|
Mengel, D;
Mok, TH;
Nihat, A;
Liu, W;
Rissman, RA;
Galasko, D;
Zetterberg, H;
... Walsh, DM; + view all
(2021)
NT1-Tau Is Increased in CSF and Plasma of CJD Patients, and Correlates with Disease Progression.
Cells
, 10
(12)
, Article 3514. 10.3390/cells10123514.
|
Michno, W;
Blennow, K;
Zetterberg, H;
Brinkmalm, G;
(2021)
Refining the amyloid β peptide and oligomer fingerprint ambiguities in Alzheimer’s disease: Mass spectrometric molecular characterization in brain, cerebrospinal fluid, blood, and plasma.
Journal of Neurochemistry
, 159
(2)
pp. 234-257.
10.1111/jnc.15466.
|
Michno, W;
Wehrli, PM;
Koutarapu, S;
Marsching, C;
Minta, K;
Ge, J;
Meyer, SW;
... Hanrieder, J; + view all
(2021)
Structural Amyloid Plaque Polymorphism is Associated with Distinct Lipid Accumulations Revealed by Trapped Ion Mobility Mass Spectrometry Imaging (TIMS MSI).
Journal of Neurochemistry
10.1111/jnc.15557.
(In press).
|
Michno, W;
Stringer, KM;
Enzlein, T;
Passarelli, MK;
Escrig, S;
Vitanova, K;
Wood, J;
... Hanrieder, J; + view all
(2021)
Following spatial Aβ aggregation dynamics in evolving Alzheimer's disease pathology by imaging stable isotope labeling kinetics.
Science Advances
, 7
(25)
10.1126/sciadv.abg4855.
|
Mielke, MM;
Frank, RD;
Dage, JL;
Jeromin, A;
Ashton, NJ;
Blennow, K;
Karikari, TK;
... Petersen, RC; + view all
(2021)
Comparison of Plasma Phosphorylated Tau Species With Amyloid and Tau Positron Emission Tomography, Neurodegeneration, Vascular Pathology, and Cognitive Outcomes.
JAMA Neurology
, 78
(9)
pp. 1108-1117.
10.1001/jamaneurol.2021.2293.
|
Mielke, MM;
Przybelski, SA;
Lesnick, TG;
Kern, S;
Zetterberg, H;
Blennow, K;
Knopman, DS;
... Vemuri, P; + view all
(2021)
Comparison of CSF neurofilament light chain, neurogranin, and tau to MRI markers.
Alzheimer's & Dementia
, 17
(5)
pp. 801-812.
10.1002/alz.12239.
|
Miki, Y;
Tsushima, E;
Foti, SC;
Strand, KM;
Asi, YT;
Yamamoto, AK;
Bettencourt, C;
... Ling, H; + view all
(2021)
Identification of multiple system atrophy mimicking Parkinson's disease or progressive supranuclear palsy.
Brain
, 144
(4)
pp. 1138-1151.
10.1093/brain/awab017.
|
Milà-Alomà, M;
Brinkmalm, A;
Ashton, NJ;
Kvartsberg, H;
Shekari, M;
Operto, G;
Salvadó, G;
... ALFA Study; + view all
(2021)
CSF Synaptic Biomarkers in the Preclinical Stage of Alzheimer Disease and Their Association With MRI and PET: A Cross-sectional Study.
Neurology
10.1212/WNL.0000000000012853.
(In press).
|
Mila-Aloma, M;
Shekari, M;
Salvado, G;
Gispert, JD;
Arenaza-Urquijo, EM;
Operto, G;
Falcon, C;
... Molinuevo, JL; + view all
(2021)
Cognitively unimpaired individuals with a low burden of A beta pathology have a distinct CSF biomarker profile.
Alzheimer's Research and Therapy
, 13
, Article 134. 10.1186/s13195-021-00863-y.
|
Millere, E;
Rots, D;
Simrén, J;
Ashton, NJ;
Kupats, E;
Micule, I;
Priedite, V;
... Kenina, V; + view all
(2021)
Plasma neurofilament light chain as a potential biomarker in Charcot‐Marie‐Tooth disease.
European Journal of Neurology
, 28
(3)
pp. 974-981.
10.1111/ene.14689.
|
Millere, E;
Rots, D;
Glazere, I;
Taurina, G;
Kurjane, N;
Priedite, V;
Gailite, L;
... Kenina, V; + view all
(2021)
Clinical Phenotyping and Biomarkers in Spinal and Bulbar Muscular Atrophy.
Frontiers in Neurology |
, 11
, Article 586610. 10.3389/fneur.2020.586610.
|
Minta, K;
Brinkmalm, G;
Thelin, EP;
Al Nimer, F;
Piehl, F;
Tullberg, M;
Jeppsson, A;
... Andreasson, U; + view all
(2021)
Cerebrospinal fluid brevican and neurocan fragment patterns in human traumatic brain injury.
Clinica Chimica Acta
, 512
pp. 74-83.
10.1016/j.cca.2020.11.017.
|
Minta, K;
Brinkmalm, G;
Portelius, E;
Johansson, P;
Svensson, J;
Kettunen, P;
Wallin, A;
... Andreasson, U; + view all
(2021)
Brevican and Neurocan Peptides as Potential Cerebrospinal Fluid Biomarkers for Differentiation Between Vascular Dementia and Alzheimer's Disease.
Journal of Alzheimer's Disease
, 79
(2)
pp. 729-741.
10.3233/JAD-201039.
|
Minta, K;
Jeppsson, A;
Brinkmalm, G;
Portelius, E;
Zetterberg, H;
Blennow, K;
Tullberg, M;
(2021)
Lumbar and ventricular CSF concentrations of extracellular matrix proteins before and after shunt surgery in idiopathic normal pressure hydrocephalus.
Fluids and Barriers of the CNS
, 18
(1)
10.1186/s12987-021-00256-1.
|
Mok, KY;
East Asian Parkinson Disease Genomics Consortium;
(2021)
The East Asian Parkinson Disease Genomics Consortium.
The Lancet Neurology
, 20
(12)
p. 982.
10.1016/S1474-4422(21)00373-2.
|
Montenegro-Venegas, Carolina;
Fienko, Sandra;
Anni, Daniela;
Pina-Fernandez, Eneko;
Frischknecht, Renato;
Fejtova, Anna;
(2021)
Bassoon inhibits proteasome activity via interaction with PSMB4.
Cellular and Molecular Life Sciences
, 78
(4)
pp. 1545-1563.
10.1007/s00018-020-03590-z.
|
Montoliu-Gaya, L;
Strydom, A;
Blennow, K;
Zetterberg, H;
Ashton, NJ;
(2021)
Blood Biomarkers for Alzheimer's Disease in Down Syndrome.
Journal of Clinical Medicine
, 10
(16)
, Article 3639. 10.3390/jcm10163639.
|
Moore, EE;
Liu, D;
Li, J;
Schimmel, SJ;
Cambronero, FE;
Terry, JG;
Nair, S;
... Jefferson, AL; + view all
(2021)
Association of Aortic Stiffness With Biomarkers of Neuroinflammation, Synaptic Dysfunction, and Neurodegeneration.
Neurology
, 97
(4)
e329-e340.
10.1212/WNL.0000000000012257.
|
Moscoso, A;
Grothe, MJ;
Ashton, NJ;
Karikari, TK;
Rodriguez, JL;
Snellman, A;
Suárez-Calvet, M;
... Alzheimer’s Disease Neuroimaging Initiative, ,; + view all
(2021)
Time course of phosphorylated-tau181 in blood across the Alzheimer's disease spectrum.
Brain
, 144
(1)
pp. 325-339.
10.1093/brain/awaa399.
|
Moscoso, A;
Grothe, MJ;
Schöll, M;
Alzheimer’s Disease Neuroimaging Initiative;
(2021)
Reduced [¹⁸F]flortaucipir retention in white matter hyperintensities compared to normal-appearing white matter.
European Journal of Nuclear Medicine and Molecular Imaging
, 48
pp. 2283-2294.
10.1007/s00259-021-05195-5.
|
Moscoso, A;
Grothe, MJ;
Ashton, NJ;
Karikari, TK;
Lantero Rodríguez, J;
Snellman, A;
Suárez-Calvet, M;
... Alzheimer’s Disease Neuroimaging Initiative, .; + view all
(2021)
Longitudinal Associations of Blood Phosphorylated Tau181 and Neurofilament Light Chain With Neurodegeneration in Alzheimer Disease.
JAMA Neurology
, 78
(4)
pp. 396-406.
10.1001/jamaneurol.2020.4986.
|
Moseby-Knappe, M;
Mattsson-Carlgren, N;
Stammet, P;
Backman, S;
Blennow, K;
Dankiewicz, J;
Friberg, H;
... Cronberg, T; + view all
(2021)
Serum markers of brain injury can predict good neurological outcome after out-of-hospital cardiac arrest.
Intensive Care Medicine
10.1007/s00134-021-06481-4.
(In press).
|
Muldmaa, M;
Mencacci, NE;
Pittman, A;
Kadastik-Eerme, L;
Sikk, K;
Taba, P;
Hardy, J;
(2021)
Community-based genetic study of Parkinson's disease in Estonia.
Acta Neurologica Scandinavica
, 143
(1)
pp. 89-95.
10.1111/ane.13329.
|
Murthy, M;
Cheng, YY;
Holton, JL;
Bettencourt, C;
(2021)
Neurodegenerative movement disorders: An epigenetics perspective and promise for the future.
Neuropathology and Applied Neurobiology
, 47
(7)
pp. 897-909.
10.1111/nan.12757.
|
N
Nair, A;
Niyogi, RK;
Shang, F;
Tabrizi, SJ;
Rees, G;
Rutledge, RB;
(2021)
Opportunity cost determines free-operant action initiation latency and predicts apathy.
Psychological Medicine
10.1017/S0033291721003469.
(In press).
|
Nair, A;
Razi, A;
Gregory, S;
Rutledge, RR;
Rees, G;
Tabrizi, SJ;
(2021)
Imbalanced basal ganglia connectivity is associated with motor deficits and apathy in Huntington's disease.
Brain
10.1093/brain/awab367.
(In press).
|
Nair, A;
Johnson, EB;
Gregory, S;
Osborne-Crowley, K;
Zeun, P;
Scahill, RI;
Lowe, J;
... Tabrizi, SJ; + view all
(2021)
Aberrant striatal value representation in Huntington’s disease gene carriers 25 years before onset.
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
10.1016/j.bpsc.2020.12.015.
(In press).
|
Najar, J;
Van der Lee, SJ;
Joas, E;
Wetterberg, H;
Hardy, J;
Guerreiro, R;
Bras, J;
... Zettergren, A; + view all
(2021)
Polygenic risk scores for Alzheimer's disease are related to dementia risk in APOE ɛ4 negatives.
Alzheimer's & Dementia
, 13
(1)
, Article e12142. 10.1002/dad2.12142.
|
Najar, J;
Hällström, T;
Zettergren, A;
Johansson, L;
Joas, E;
Fässberg, MM;
Zetterberg, H;
... Skoog, I; + view all
(2021)
Reproductive period and preclinical cerebrospinal fluid markers for Alzheimer disease: a 25-year study.
Menopause
10.1097/GME.0000000000001816.
(In press).
|
Natarajan, K;
Ullgren, A;
Khoshnood, B;
Johansson, C;
Laffita-Mesa, JM;
Pannee, J;
Zetterberg, H;
... Graff, C; + view all
(2021)
Plasma metabolomics of presymptomatic PSEN1-H163Y mutation carriers: a pilot study.
Annals of Clinical and Translational Neurology
10.1002/acn3.51296.
(In press).
|
Nazir, FH;
Camporesi, E;
Brinkmalm, G;
Lashley, T;
Toomey, CE;
Kvartsberg, H;
Zetterberg, H;
... Becker, B; + view all
(2021)
Molecular forms of neurogranin in cerebrospinal fluid.
Journal of Neurochemistry
10.1111/jnc.15252.
(In press).
|
Nazish, I;
Arber, C;
Piers, TM;
Warner, TT;
Hardy, JA;
Lewis, PA;
Pocock, JM;
(2021)
Abrogation of LRRK2 dependent Rab10 phosphorylation with TLR4 activation and alterations in evoked cytokine release in immune cells.
Neurochemistry International
, 147
, Article 105070. 10.1016/j.neuint.2021.105070.
|
Needham, EJ;
Stoevesandt, O;
Thelin, EP;
Zetterberg, H;
Zanier, ER;
Al Nimer, F;
Ashton, NJ;
... Coles, AJ; + view all
(2021)
Complex Autoantibody Responses Occur following Moderate to Severe Traumatic Brain Injury.
The Journal of Immunology
, 207
(1)
pp. 90-100.
10.4049/jimmunol.2001309.
|
Neitzel, J;
Franzmeier, N;
Rubinski, A;
Dichgans, M;
Brendel, M;
Alzheimer’s Disease Neuroimaging Initiative (ADNI), .;
Malik, R;
(2021)
KL-VS heterozygosity is associated with lower amyloid-dependent tau accumulation and memory impairment in Alzheimer's disease.
Nature Communications
, 12
(1)
, Article 3825. 10.1038/s41467-021-23755-z.
|
Neves, JB;
Varley, R;
Agnesi, S;
Withington, J;
Rodrigues, FB;
Warren, H;
Yuminaga, Y;
... Tran, MGB; + view all
(2021)
Growth and renal function dynamics of renal oncocytomas on active surveillance.
BJU International
10.1111/bju.15499.
(In press).
|
Ng, J;
Barral, S;
Barrigon, CDLF;
Lignani, G;
Erdem, FA;
Wallings, R;
Privolizzi, R;
... Kurian, MA; + view all
(2021)
Gene therapy restores dopamine transporter expression and ameliorates pathology in iPSC and mouse models of infantile parkinsonism.
Science Translational Medicine
, 13
(594)
, Article eaaw1564. 10.1126/scitranslmed.aaw1564.
|
Niemi, MEK;
Karjalainen, J;
Liao, RG;
Neale, BM;
Daly, M;
Ganna, A;
Pathak, GA;
... Donohue, C; + view all
(2021)
Mapping the human genetic architecture of COVID-19.
Nature
, 600
pp. 472-477.
10.1038/s41586-021-03767-x.
|
Nilsson, J;
Gobom, J;
Sjödin, S;
Brinkmalm, G;
Ashton, NJ;
Svensson, J;
Johansson, P;
... Brinkmalm, A; + view all
(2021)
Cerebrospinal fluid biomarker panel for synaptic dysfunction in Alzheimer's disease.
Alzheimers Dementia
, 13
(1)
, Article e12179. 10.1002/dad2.12179.
|
North, C;
Desai, R;
Saunders, R;
Suárez-González, A;
Bamiou, D;
Costafreda, SG;
de Haan, G;
... Stott, J; + view all
(2021)
Neuropsychological deficits in Posterior Cortical Atrophy and typical Alzheimer's disease: A meta-analytic review.
Cortex
, 143
pp. 223-236.
10.1016/j.cortex.2021.07.011.
|
Noyce, Alastair;
(2021)
GP2 : The Global Parkinson's Genetics Program.
Movement Disorders
10.1002/mds.28494.
(In press).
|
O
O'Connor, A;
Abel, E;
Fraser, MR;
Ryan, NS;
Jiménez, DA;
Koriath, C;
Chávez-Gutiérrez, L;
... Fox, NC; + view all
(2021)
A novel presenilin 1 duplication mutation (Ile168dup) causing Alzheimer's disease associated with myoclonus, seizures and pyramidal features.
Neurobiology of Aging
, 103
137.e1-137.e5.
10.1016/j.neurobiolaging.2021.01.032.
|
O'Connor, A;
Pannee, J;
Poole, T;
Arber, C;
Portelius, E;
Swift, IJ;
Heslegrave, AJ;
... Fox, NC; + view all
(2021)
Plasma amyloid-β ratios in autosomal dominant Alzheimer's disease: the influence of genotype.
Brain
10.1093/brain/awab166.
(In press).
|
O'Regan, GC;
Farag, SH;
Casey, CS;
Wood-Kaczmar, A;
Pocock, JM;
Tabrizi, SJ;
Andre, R;
(2021)
Human Huntington's disease pluripotent stem cell-derived microglia develop normally but are abnormally hyper-reactive and release elevated levels of reactive oxygen species.
Journal of Neuroinflammation
, 18
, Article 94. 10.1186/s12974-021-02147-6.
|
Oosterloo, M;
de Greef, BTA;
Bijlsma, EK;
Durr, A;
Tabrizi, SJ;
Estevez-Fraga, C;
de Die-Smulders, CEM;
(2021)
Disease Onset in Huntington's Disease: When Is the Conversion?
Movement Disorders Clinical Practice
10.1002/mdc3.13148.
(In press).
|
Ossenkoppele, R;
Reimand, J;
Smith, R;
Leuzy, A;
Strandberg, O;
Palmqvist, S;
Stomrud, E;
... Hansson, O; + view all
(2021)
Tau PET correlates with different Alzheimer's disease-related features compared to CSF and plasma p-tau biomarkers.
EMBO Molecular Medicine
, Article e14398. 10.15252/emmm.202114398.
|
Oxtoby, N;
Leyland, L;
Aksman, L;
Thomas, G;
Bunting, E;
Wijeratne, P;
Young, A;
... Weil, R; + view all
(2021)
Sequence of clinical and neurodegeneration events in Parkinson’s disease progression.
Brain
, Article awaa461. 10.1093/brain/awaa461.
|
P
Pairo-Castineira, E;
Clohisey, S;
Klaric, L;
Bretherick, AD;
Rawlik, K;
Pasko, D;
Walker, S;
... Baillie, JK; + view all
(2021)
Genetic mechanisms of critical illness in COVID-19.
Nature
, 591
pp. 92-98.
10.1038/s41586-020-03065-y.
|
Palmqvist, S;
Tideman, P;
Cullen, N;
Zetterberg, H;
Blennow, K;
Dage, JL;
Stomrud, E;
... Hansson, O; + view all
(2021)
Prediction of future Alzheimer's disease dementia using plasma phospho-tau combined with other accessible measures.
Nature Medicine
, 27
pp. 1034-1042.
10.1038/s41591-021-01348-z.
|
Panman, JL;
Venkatraghavan, V;
van der Ende, EL;
Steketee, RME;
Jiskoot, LC;
Poos, JM;
Dopper, EGP;
... GENFI consortium investigators; + view all
(2021)
Modelling the cascade of biomarker changes in GRN-related frontotemporal dementia.
Journal of Neurology, Neurosurgery and Psychiatry
10.1136/jnnp-2020-323541.
(In press).
|
Pannee, J;
Shaw, LM;
Korecka, M;
Waligorska, T;
Teunissen, CE;
Stoops, E;
Vanderstichele, HMJ;
... Zetterberg, H; + view all
(2021)
The global Alzheimer's Association round robin study on plasma amyloid β methods.
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
, 13
(1)
, Article e12242. 10.1002/dad2.12242.
|
Parker, CS;
Veale, T;
Bocchetta, M;
Slattery, CF;
Malone, IB;
Thomas, DL;
Schott, JM;
... Zhang, H; + view all
(2021)
Not all voxels are created equal: reducing estimation bias in regional NODDI metrics using tissue-weighted means.
NeuroImage
, Article 118749. 10.1016/j.neuroimage.2021.118749.
(In press).
|
Pascoal, TA;
Benedet, AL;
Ashton, NJ;
Kang, MS;
Therriault, J;
Chamoun, M;
Savard, M;
... Rosa-Neto, P; + view all
(2021)
Microglial activation and tau propagate jointly across Braak stages.
Nature Medicine
, 27
pp. 1592-1599.
10.1038/s41591-021-01456-w.
|
Patel, H;
Ashton, NJ;
Dobson, RJB;
Andersson, L-M;
Yilmaz, A;
Blennow, K;
Gisslen, M;
(2021)
Proteomic blood profiling in mild, severe and critical COVID-19 patients.
Scientific Reports
, 11
, Article 6357. 10.1038/s41598-021-85877-0.
|
Paterson, RW;
Benjamin, LA;
Mehta, PR;
Brown, RL;
Athauda, D;
Ashton, NJ;
Leckey, CA;
... Schott, JM; + view all
(2021)
Serum and cerebrospinal fluid biomarker profiles in acute SARS-CoV-2-associated neurological syndromes.
Brain Communications
, 3
(3)
, Article fcab099. 10.1093/braincomms/fcab099.
|
Pavisic, IM;
Nicholas, JM;
Pertzov, Y;
O'Connor, A;
Liang, Y;
Collins, JD;
Lu, K;
... Crutch, SJ; + view all
(2021)
Visual short-term memory impairments in presymptomatic familial Alzheimer's disease: A longitudinal observational study.
Neuropsychologia
, 162
, Article 108028. 10.1016/j.neuropsychologia.2021.108028.
|
Pavisic, Ivanna Micol;
(2021)
Detecting and tracking populations at-risk of Alzheimer’s disease: studying asymptomatic cognitive profiles and symptomatic clinical presentations.
Doctoral thesis (Ph.D), UCL (University College London).
|
Pavisic, IM;
Lu, K;
Keuss, SE;
James, S-N;
Lane, CA;
Parker, TD;
Keshavan, A;
... Schott, JM; + view all
(2021)
Subjective cognitive complaints at age 70: associations with amyloid and mental health.
Journal of Neurology, Neurosurgery and Psychiatry
10.1136/jnnp-2020-325620.
(In press).
|
Pavisic, IM;
Pertzov, Y;
Nicholas, JM;
O’Connor, A;
Lu, K;
Yong, KXX;
Husain, M;
... Crutch, SJ; + view all
(2021)
Eye-tracking indices of impaired encoding of visual short-term memory in familial Alzheimer’s disease.
Scientific Reports
, 11
, Article 8696. 10.1038/s41598-021-88001-4.
(In press).
|
Peakman, G;
Russell, LL;
Convery, RS;
Nicholas, JM;
van Swieten, JC;
Jiskoot, LC;
Moreno, F;
... Mitchell, S; + view all
(2021)
Comparison of clinical rating scales in genetic frontotemporal dementia within the GENFI cohort.
Journal of Neurology, Neurosurgery and Psychiatry
10.1136/jnnp-2021-326868.
(In press).
|
Pemberton, HG;
Goodkin, O;
Prados, F;
Das, RK;
Vos, SB;
Moggridge, J;
Coath, W;
... Alzheimer’s Disease Neuroimaging Initiative; + view all
(2021)
Automated quantitative MRI volumetry reports support diagnostic interpretation in dementia: a multi-rater, clinical accuracy study.
European Radiology
10.1007/s00330-020-07455-8.
(In press).
|
Penn, D;
Lanceley, A;
Petrie, A;
Nicholls, J;
(2021)
Mental capacity assessment: a descriptive, cross-sectional study of what doctors think, know and do.
Journal of Medical Ethics
, 47
(12)
, Article e6. 10.1136/medethics-2019-105819.
|
Pereira, JB;
Janelidze, S;
Smith, R;
Mattsson-Carlgren, N;
Palmqvist, S;
Teunissen, CE;
Zetterberg, H;
... Hansson, O; + view all
(2021)
Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer's disease.
Brain
, Article awab223. 10.1093/brain/awab223.
(In press).
|
Perino, J;
Patterson, M;
Momen, M;
Borisova, M;
Heslegrave, A;
Zetterberg, H;
Gruel, J;
... Sample, SJ; + view all
(2021)
Neurofilament light plasma concentration positively associates with age and negatively associates with weight and height in the dog.
Neuroscience Letters
, 744
, Article 135593. 10.1016/j.neulet.2020.135593.
|
Picard, C;
Nilsson, N;
Labonté, A;
Auld, D;
Rosa-Neto, P;
Alzheimer's Disease Neuroimaging Initiative;
Ashton, NJ;
... PREVENT-AD research group; + view all
(2021)
Apolipoprotein B is a novel marker for early tau pathology in Alzheimer's disease.
Alzheimer's & Dementia: The Journal of the Alzheimer's Association
10.1002/alz.12442.
(In press).
|
Pichet Binette, A;
Poirier, J;
Breitner, JCS;
Villeneuve, S;
Vachon-Presseau, É;
Collins, DL;
Villeneuve, S;
... Sohrabi, H; + view all
(2021)
Amyloid and Tau Pathology Associations With Personality Traits, Neuropsychiatric Symptoms, and Cognitive Lifestyle in the Preclinical Phases of Sporadic and Autosomal Dominant Alzheimer's Disease.
Biological Psychiatry
, 89
(8)
pp. 776-785.
10.1016/j.biopsych.2020.01.023.
|
Pilotto, A;
Imarisio, A;
Conforti, F;
Scalvini, A;
Masciocchi, S;
Nocivelli, S;
Turrone, R;
... Padovani, A; + view all
(2021)
Plasma NfL, clinical subtypes and motor progression in Parkinson's disease.
Parkinsonism & Related Disorders
, 87
pp. 41-47.
10.1016/j.parkreldis.2021.04.016.
|
Pilotto, A;
Masciocchi, S;
Volonghi, I;
De Giuli, V;
Caprioli, F;
Mariotto, S;
Ferrari, S;
... Padovani, A; + view all
(2021)
SARS-CoV-2 encephalitis is a cytokine release syndrome: evidences from cerebrospinal fluid analyses.
Clinical Infectious Diseases
, 73
(9)
e3019-e3026.
10.1093/cid/ciaa1933.
|
Pilotto, A;
Imarisio, A;
Carrarini, C;
Russo, M;
Masciocchi, S;
Gipponi, S;
Cottini, E;
... Padovani, A; + view all
(2021)
Plasma Neurofilament Light Chain Predicts Cognitive Progression in Prodromal and Clinical Dementia with Lewy Bodies.
Journal of Alzheimer's Disease
10.3233/JAD-210342.
(In press).
|
Pomara, N;
Bruno, D;
Plaska, CR;
Pillai, A;
Ramos-Cejudo, J;
Osorio, R;
Imbimbo, BP;
... Blennow, K; + view all
(2021)
Evidence of upregulation of the cholinergic anti-inflammatory pathway in late-life depression.
Journal of Affective Disorders
, 286
pp. 275-281.
10.1016/j.jad.2021.03.012.
|
Poon, A;
Saini, H;
Sethi, S;
O'Sullivan, GA;
Plun-Favreau, H;
Wray, S;
Dawson, LA;
(2021)
The role of SQSTM1 (p62) in mitochondrial function and clearance in human cortical neurons.
Stem Cell Reports
10.1016/j.stemcr.2021.03.030.
(In press).
|
Poos, JM;
Russell, LL;
Peakman, G;
Bocchetta, M;
Greaves, CV;
Jiskoot, LC;
van der Ende, EL;
... Genetic FTD Initiative, GENF; + view all
(2021)
Impairment of episodic memory in genetic frontotemporal dementia: A GENFI study.
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
, 13
(1)
, Article e12185. 10.1002/dad2.12185.
|
Premi, E;
Giunta, M;
Iraji, A;
Rachakonda, S;
Calhoun, VD;
Gazzina, S;
Benussi, A;
... Borroni, B; + view all
(2021)
Dissemination in time and space in presymptomatic granulin mutation carriers: a GENFI spatial chronnectome study.
Neurobiology of Aging
, 108
pp. 155-167.
10.1016/j.neurobiolaging.2021.09.001.
|
Puentes, F;
Lombardi, V;
Lu, C-H;
Yildiz, O;
Fratta, P;
Isaacs, A;
Bobeva, Y;
... Malaspina, A; + view all
(2021)
Humoral response to neurofilaments and dipeptide repeats in ALS progression.
Annals of Clinical and Translational Neurology
10.1002/acn3.51428.
(In press).
|
Pujol-Calderón, F;
Zetterberg, H;
Portelius, E;
Löwhagen Hendén, P;
Rentzos, A;
Karlsson, J-E;
Höglund, K;
... Rosengren, LE; + view all
(2021)
Prediction of Outcome After Endovascular Embolectomy in Anterior Circulation Stroke Using Biomarkers.
Translational Stroke Research
10.1007/s12975-021-00905-5.
(In press).
|
Q
Quint, WH;
Matečko-Burmann, I;
Schilcher, I;
Löffler, T;
Schöll, M;
Burmann, BM;
Vogels, T;
(2021)
Bispecific Tau Antibodies with Additional Binding to C1q or Alpha-Synuclein.
Journal of Alzheimer's Disease
, 80
(2)
pp. 813-829.
10.3233/JAD-201334.
|
R
Rådestig, MA;
Skoog, J;
Zetterberg, H;
Kern, J;
Zettergren, A;
Sacuiu, S;
Waern, M;
... Kern, S; + view all
(2021)
Cognitive Performance and Cerebrospinal Fluid Markers in Preclinical Alzheimer's Disease: Results from the Gothenburg H70 Birth Cohort Studies.
Journal of Alzheimer's Disease
, 79
(1)
pp. 225-235.
10.3233/JAD-200751.
|
Raftopoulos, R;
Kuhle, J;
Grant, D;
Hickman, SJ;
Altmann, DR;
Leppert, D;
Blennow, K;
... Gnanapavan, S; + view all
(2021)
Neurofilament results for the phase II neuroprotection study of phenytoin in optic neuritis.
European Journal of Neurology
, 28
(2)
pp. 587-594.
10.1111/ene.14591.
|
Raposo, M;
Bettencourt, C;
Melo, ARV;
Ferreira, AF;
Alonso, I;
Silva, P;
Vasconcelos, J;
... Lima, M; + view all
(2021)
Novel Machado-Joseph disease-modifying genes and pathways identified by whole-exome sequencing.
Neurobiology of Disease
, 162
, Article 105578. 10.1016/j.nbd.2021.105578.
|
Remnestål, J;
Bergström, S;
Olofsson, J;
Sjöstedt, E;
Uhlén, M;
Blennow, K;
Zetterberg, H;
... Månberg, A; + view all
(2021)
Association of CSF proteins with tau and amyloid β levels in asymptomatic 70-year-olds.
Alzheimer's Research & Therapy
, 13
, Article 54. 10.1186/s13195-021-00789-5.
|
Reus, LM;
Pasaniuc, B;
Posthuma, D;
Boltz, T;
Pijnenburg, YAL;
Ophoff, RA;
(2021)
Gene Expression Imputation Across Multiple Tissue Types Provides Insight Into the Genetic Architecture of Frontotemporal Dementia and Its Clinical Subtypes.
Biological Psychiatry
, 89
(8)
pp. 825-835.
10.1016/j.biopsych.2020.12.023.
|
Robert, A;
Schöll, M;
Vogels, T;
(2021)
Tau Seeding Mouse Models with Patient Brain-Derived Aggregates.
International Journal of Molecular Sciences
, 22
(11)
, Article 6132. 10.3390/ijms22116132.
|
Robertson, J;
Edèn, A;
Nyström, K;
Hagberg, L;
Yilmaz, A;
Gostner, JM;
Fuchs, D;
... Gisslèn, M; + view all
(2021)
Increased immune activation and signs of neuronal injury in HIV-negative people on preexposure prophylaxis.
AIDS
, 35
(13)
pp. 2129-2136.
10.1097/QAD.0000000000002980.
|
Rojas, JC;
Wang, P;
Staffaroni, AM;
Heller, C;
Cobigo, Y;
Wolf, A;
Goh, S-YM;
... Boxer, AL; + view all
(2021)
Plasma Neurofilament Light for Prediction of Disease Progression in Familial Frontotemporal Lobar Degeneration.
Neurology
10.1212/WNL.0000000000011848.
(In press).
|
Rosadas, C;
Zetterberg, H;
Heslegrave, A;
Haddow, J;
Borisova, M;
Taylor, GP;
(2021)
Neurofilament Light in CSF and Plasma Is a Marker of Neuronal Damage in HTLV-1-Associated Myelopathy and Correlates With Neuroinflammation.
Neurology Neuroimmunology & Neuroinflammation
, 8
(6)
, Article e1090. 10.1212/NXI.0000000000001090.
|
Rosenstein, I;
Axelsson, M;
Novakova, L;
Blennow, K;
Zetterberg, H;
Lycke, J;
(2021)
Exploring CSF neurofilament light as a biomarker for MS in clinical practice; a retrospective registry-based study.
Multiple Sclerosis Journal
10.1177/13524585211039104.
(In press).
|
Rosenstein, I;
Rasch, S;
Axelsson, M;
Novakova, L;
Blennow, K;
Zetterberg, H;
Lycke, J;
(2021)
Kappa free light chain index as a diagnostic biomarker in multiple sclerosis: a real-world investigation.
Journal of Neurochemistry
10.1111/jnc.15500.
(In press).
|
Rossignoli, G;
Krämer, K;
Lugarà, E;
Alrashidi, H;
Pope, S;
De La Fuente Barrigon, C;
Barwick, K;
... Kurian, MA; + view all
(2021)
Aromatic L-amino acid decarboxylase deficiency: a patient-derived neuronal model for precision therapies.
Brain
10.1093/brain/awab123.
(In press).
|
Rossor, AM;
Kapoor, M;
Wellington, H;
Spaulding, EL;
Sleigh, JN;
Burgess, RW;
Laura, M;
... Mm, R; + view all
(2021)
A longitudinal and cross-sectional study of plasma neurofilament light chain concentration in Charcot-Marie-Tooth disease.
Journal of the Peripheral Nervous System
10.1111/jns.12477.
(In press).
|
Rostagno, A;
Calero, M;
Holton, JL;
Revesz, T;
Lashley, T;
Ghiso, J;
(2021)
Association of clusterin with the BRI2-derived amyloid molecules ABri and ADan.
Neurobiology of Disease
, 158
, Article 105452. 10.1016/j.nbd.2021.105452.
|
Ruksenaite, J;
Volkmer, A;
Jiang, J;
Johnson, JC;
Marshall, CR;
Warren, JD;
Hardy, CJ;
(2021)
Primary Progressive Aphasia: Toward a Pathophysiological Synthesis.
Current Neurology and Neuroscience Reports
, 21
, Article 7. 10.1007/s11910-021-01097-z.
|
Rupprechter, S;
Morinan, G;
Peng, Y;
Foltynie, T;
Sibley, K;
Weil, RS;
Leyland, LA;
... O’Keeffe, J; + view all
(2021)
A clinically interpretable computer-vision based method for quantifying gait in parkinson’s disease.
Sensors
, 21
(16)
, Article 5437. 10.3390/s21165437.
|
Russell, LL;
Greaves, CV;
Convery, RS;
Bocchetta, M;
Warren, JD;
Kaski, D;
Rohrer, JD;
(2021)
Eye movements in frontotemporal dementia: Abnormalities of fixation, saccades and anti-saccades.
Alzheimer's & Dementia: Translational Research & Clinical Interventions
, 7
(1)
, Article e12218. 10.1002/trc2.12218.
|
Russell, LL;
Greaves, CV;
Convery, RS;
Nicholas, J;
Warren, JD;
Kaski, D;
Rohrer, JD;
(2021)
Novel instructionless eye tracking tasks identify emotion recognition deficits in frontotemporal dementia.
Alzheimer's Research & Therapy
, 13
, Article 39. 10.1186/s13195-021-00775-x.
|
S
Salami, A;
Adolfsson, R;
Andersson, M;
Blennow, K;
Lundquist, A;
Adolfsson, AN;
Schöll, M;
... Nyberg, L; + view all
(2021)
Association of APOE ɛ4 and Plasma p-tau181 with Preclinical Alzheimer's Disease and Longitudinal Change in Hippocampus Function.
Journal of Alzheimer's Disease
10.3233/JAD-210673.
(In press).
|
Salih, D;
Chaney, AM;
(2021)
Prodromal neuroinflammatory, cholinergic and metabolite dysfunction detected by PET and MRS in the TgF344-AD transgenic rat model of AD - a multi-modal and multi-centre study.
Theranostics
, 11
(4)
pp. 6644-6667.
10.7150/thno.56059.
|
Salvado, G;
Grothe, MJ;
Groot, C;
Moscoso, A;
Scholl, M;
Gispert, JD;
Ossenkoppele, R;
(2021)
Differential associations of APOE-epsilon 2 and APOE-epsilon 4 alleles with PET-measured amyloid-beta and tau deposition in older individuals without dementia.
European Journal of Nuclear Medicine and Molecular Imaging
10.1007/s00259-021-05192-8.
(In press).
|
Salvadó, G;
Milà-Alomà, M;
Shekari, M;
Minguillon, C;
Fauria, K;
Niñerola-Baizán, A;
Perissinotti, A;
... Gispert, JD; + view all
(2021)
Cerebral amyloid‐β load is associated with neurodegeneration and gliosis: Mediation by p‐tau and interactions with risk factors early in the Alzheimer's continuum.
Alzheimer's & Dementia
, 17
(5)
pp. 788-800.
10.1002/alz.12245.
|
Salzmann, A;
James, SN;
Williams, D;
Richards, M;
Cadar, D;
Schott, J;
Coath, W;
... Garfield, V; + view all
(2021)
Investigating the relationship between IGF-I, -II and IGFBP-3 concentrations and later-life cognition and brain volume.
Journal of Clinical Endocrinology and Metabolism
, 106
(6)
pp. 1617-1629.
10.1210/clinem/dgab121.
|
Samanci, B;
Bilgiç, B;
Gelişin, Ö;
Tepgeç, F;
Guven, G;
Tüfekçioğlu, Z;
Alaylıoğlu, M;
... Emre, M; + view all
(2021)
TREM2 Variants as A Possible Cause of Frontotemporal Dementia with Distinct Neuroimaging Features.
European Journal of Neurology
, 28
(8)
pp. 2603-2613.
10.1111/ene.14908.
|
Samuelsson, J;
Najar, J;
Wallengren, O;
Kern, S;
Wetterberg, H;
Mellqvist Fässberg, M;
Zetterberg, H;
... Zettergren, A; + view all
(2021)
Interactions between dietary patterns and genetic factors in relation to incident dementia among 70-year-olds.
European Journal of Nutrition
10.1007/s00394-021-02688-9.
(In press).
|
Samuelsson, J;
Kern, S;
Zetterberg, H;
Blennow, K;
Rothenberg, E;
Wallengren, O;
Skoog, I;
(2021)
A Western-style dietary pattern is associated with cerebrospinal fluid biomarker levels for preclinical Alzheimer's disease-A population-based cross-sectional study among 70-year-olds.
Alzheimer's & Dementia: Translational Research & Clinical Interventions
, 7
(1)
, Article e12183. 10.1002/trc2.12183.
|
Sanchez, II;
Nguyen, TB;
England, WE;
Lim, RG;
Vu, AQ;
Miramontes, R;
Byrne, LM;
... Thompson, LM; + view all
(2021)
Huntington's disease mice and human brain tissue exhibit increased G3BP1 granules and TDP43 mislocalization.
Journal of Clinical Investigation
, 131
(12)
, Article e140723. 10.1172/JCI140723.
|
Sánchez, JA;
Gil-Martinez, AL;
Cisterna, A;
García-Ruíz, S;
Gómez-Pascual, A;
Reynolds, RH;
Nalls, M;
... Botía, JA; + view all
(2021)
Modeling multifunctionality of genes with secondary gene co-expression networks in human brain provides novel disease insights.
Bioinformatics
10.1093/bioinformatics/btab175.
(In press).
|
Sánchez-Benavides, G;
Suárez-Calvet, M;
Milà-Alomà, M;
Arenaza-Urquijo, EM;
Grau-Rivera, O;
Operto, G;
Gispert, JD;
... ALFA Study; + view all
(2021)
Amyloid-β positive individuals with subjective cognitive decline present increased CSF neurofilament light levels that relate to lower hippocampal volume.
Neurobiology of Aging
, 104
pp. 24-31.
10.1016/j.neurobiolaging.2021.02.026.
|
Sanders, RD;
Craigova, L;
Schessler, B;
Casey, C;
White, M;
Parker, M;
Kunkel, D;
... Lennertz, R; + view all
(2021)
Postoperative troponin increases after noncardiac surgery are associated with raised neurofilament light: a prospective observational cohort study.
British Journal of Anaesthesia
, 126
(4)
pp. 791-798.
10.1016/j.bja.2020.10.012.
|
Sanderson, LE;
Lanko, K;
Alsagob, M;
Almass, R;
Al-Ahmadi, N;
Najafi, M;
Al-Muhaizea, MA;
... Kaya, N; + view all
(2021)
Bi-allelic variants in HOPS complex subunit VPS41 cause cerebellar ataxia and abnormal membrane trafficking.
Brain
, 144
(3)
pp. 769-780.
10.1093/brain/awaa459.
|
Savage, Sharon A;
Suárez-González, Aida;
Cassani, Alice;
Gopalan, Ragaviveka;
Stott, Joshua;
(2021)
Non-primary progressive language impairment in neurodegenerative conditions: protocol for a scoping review.
Systematic Reviews
, 10
, Article 32. 10.1186/s13643-021-01589-6.
|
Savage, SA;
Suárez-González, A;
Cassani, A;
Gopalan, R;
Stott, J;
(2021)
Non-primary progressive language impairment in neurodegenerative conditions: protocol for a scoping review.
Systematic Reviews
, 10
, Article 32. 10.1186/s13643-021-01589-6.
|
Sayed, Faten A;
Kodama, Lay;
Fan, Li;
Carling, Gillian K;
Udeochu, Joe C;
Le, David;
Li, Qingyun;
... Gan, Li; + view all
(2021)
AD-linked R47H-TREM2 mutation induces disease-enhancing microglial states via AKT hyperactivation.
Science Translational Medicine
, 13
(622)
, Article eabe3947. 10.1126/scitranslmed.abe3947.
|
Scaglioni, D;
Catapano, F;
Ellis, M;
Torelli, S;
Chambers, D;
Feng, L;
Beck, M;
... Muntoni, F; + view all
(2021)
The administration of antisense oligonucleotide golodirsen reduces pathological regeneration in patients with Duchenne muscular dystrophy.
Acta Neuropathologica Communications
, 9
(1)
, Article 7. 10.1186/s40478-020-01106-1.
|
Scheltens, P;
De Strooper, B;
Kivipelto, M;
Holstege, H;
Chételat, G;
Teunissen, CE;
Cummings, J;
(2021)
Alzheimer's disease.
The Lancet
, 397
(10284)
pp. 1577-1590.
10.1016/S0140-6736(20)32205-4.
|
Schindler, F;
Praedel, N;
Neuendorf, N;
Kunz, S;
Schnoegl, S;
Mason, MA;
Taxy, BA;
... Wanker, EE; + view all
(2021)
Small, Seeding-Competent Huntingtin Fibrils Are Prominent Aggregate Species in Brains of zQ175 Huntington's Disease Knock-in Mice.
Frontiers in Neuroscience
, 15
, Article 682172. 10.3389/fnins.2021.682172.
|
Schulze-Krebs, A;
Canneva, F;
Stemick, J;
Plank, AC;
Harrer, J;
Bates, GP;
Aeschlimann, D;
... Von Hörsten, S; + view all
(2021)
Transglutaminase 6 Is Colocalized and Interacts with Mutant Huntingtin in Huntington Disease Rodent Animal Models.
International Journal of Molecular Sciences
, 22
(16)
, Article 8914. 10.3390/ijms22168914.
|
Seto-Salvia, N;
Esteras, N;
de Silva, R;
de Pablo-Fernandez, E;
Arber, C;
Toomey, CE;
Polke, JM;
... Warner, TT; + view all
(2021)
Elevated 4R-tau in astrocytes from asymptomatic carriers of the MAPT 10+16 intronic mutation.
Journal of Cellular and Molecular Medicine
10.1111/jcmm.17136.
(In press).
|
Shahim, P;
Zetterberg, H;
(2021)
Neurochemical markers of traumatic brain injury – relevance to acute diagnostics, disease monitoring, and neuropsychiatric outcome prediction.
Biological Psychiatry
10.1016/j.biopsych.2021.10.010.
(In press).
|
Shen, XN;
Huang, YY;
Chen, SD;
Guo, Y;
Tan, L;
Dong, Q;
Yu, JT;
... Shaw, LM; + view all
(2021)
Plasma phosphorylated-tau181 as a predictive biomarker for Alzheimer’s amyloid, tau and FDG PET status.
Translational Psychiatry
, 11
, Article 585. 10.1038/s41398-021-01709-9.
|
Shepley, BR;
Ainslie, PN;
Hoiland, RL;
Donnelly, J;
Sekhon, MS;
Zetterberg, H;
Blennow, K;
(2021)
Negligible influence of moderate to severe hyperthermia on blood-brain barrier permeability and neuronal-parenchymal integrity in healthy men.
Journal of Applied Physiology
, 130
(3)
pp. 792-800.
10.1152/japplphysiol.00645.2020.
|
Shi, L;
Winchester, LM;
Westwood, S;
Baird, AL;
Anand, SN;
Buckley, NJ;
Hye, A;
... Nevado-Holgado, AJ; + view all
(2021)
Replication study of plasma proteins relating to Alzheimer's pathology.
Alzheimer's and Dementia
, 17
(9)
pp. 1452-1464.
10.1002/alz.12322.
|
Shi, Y;
Zhang, W;
Yang, Y;
Murzin, AG;
Falcon, B;
Kotecha, A;
van Beers, M;
... Scheres, SHW; + view all
(2021)
Structure-based classification of tauopathies.
Nature
, 598
pp. 359-363.
10.1038/s41586-021-03911-7.
|
Shi, L;
Buckley, NJJ;
Bos, I;
Engelborghs, S;
Sleegers, K;
Frisoni, GB;
Wallin, A;
... Nevado-Holgado, AJ; + view all
(2021)
Plasma Proteomic Biomarkers Relating to Alzheimer's Disease: A Meta-Analysis Based on Our Own Studies.
Frontiers in Aging Neuroscience
, 13
, Article 712545. 10.3389/fnagi.2021.712545.
|
Shribman, S;
Bocchetta, M;
Sudre, CH;
Acosta-Cabronero, J;
Burrows, M;
Cook, P;
Thomas, DL;
... Warner, TT; + view all
(2021)
Neuroimaging correlates of brain injury in Wilson's disease: a multimodal, whole-brain MRI study.
Brain
10.1093/brain/awab274.
(In press).
|
Sievers, P;
Henneken, SC;
Blume, C;
Sill, M;
Schrimpf, D;
Stichel, D;
Okonechnikov, K;
... Sahm, F; + view all
(2021)
Recurrent fusions in PLAGL1 define a distinct subset of pediatric-type supratentorial neuroepithelial tumors.
Acta Neuropathologica
10.1007/s00401-021-02356-6.
(In press).
|
Simone, R;
Javad, F;
Emmett, W;
Wilkins, OG;
Almeida, FL;
Barahona-Torres, N;
Zareba-Paslawska, J;
... De Silva, R; + view all
(2021)
MIR-NATs repress MAPT translation and aid proteostasis in neurodegeneration.
Nature
, 594
pp. 117-123.
10.1038/s41586-021-03556-6.
|
Simrén, J;
Leuzy, A;
Karikari, TK;
Hye, A;
Benedet, AL;
Lantero-Rodriguez, J;
Mattsson-Carlgren, N;
... Ashton, NJ; + view all
(2021)
The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer's disease.
Alzheimer's & Dementia
, 17
(7)
pp. 1145-1156.
10.1002/alz.12283.
|
Simrén, J;
Ashton, NJ;
Blennow, K;
Zetterberg, H;
(2021)
Blood neurofilament light in remote settings: Alternative protocols to support sample collection in challenging pre-analytical conditions.
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
, 13
(1)
, Article e12145. 10.1002/dad2.12145.
|
Sivasathiaseelan, H;
Marshall, CR;
Benhamou, E;
van Leeuwen, JEP;
Bond, RL;
Russell, LL;
Greaves, C;
... Warren, JD; + view all
(2021)
Laughter as a paradigm of socio-emotional signal processing in dementia.
Cortex
, 142
pp. 186-203.
10.1016/j.cortex.2021.05.020.
|
Sjöbom, U;
Hellström, W;
Löfqvist, C;
Nilsson, AK;
Holmström, G;
Pupp, IH;
Ley, D;
... Hellström, A; + view all
(2021)
Analysis of Brain Injury Biomarker Neurofilament Light and Neurodevelopmental Outcomes and Retinopathy of Prematurity Among Preterm Infants.
Jama Network Open
, 4
(4)
, Article e214138. 10.1001/jamanetworkopen.2021.4138.
|
Skillbäck, T;
Blennow, K;
Zetterberg, H;
Shams, S;
Machado, A;
Pereira, J;
Lindberg, O;
... Kern, S; + view all
(2021)
Sex differences in CSF biomarkers for neurodegeneration and blood-brain barrier integrity.
Alzheimers Dement (Amst)
, 13
(1)
, Article e12141. 10.1002/dad2.12141.
|
Skoog, I;
Kern, S;
Najar, J;
Guerreiro, R;
Bras, J;
Waern, M;
Zetterberg, H;
... Zettergren, A; + view all
(2021)
A non-APOE polygenic risk score for Alzheimer's disease is associated with CSF neurofilament light in a representative sample of cognitively unimpaired 70-year-olds.
The Journals of Gerontology: Series A
10.1093/gerona/glab030.
(In press).
|
Smith, R;
Strain, J;
Tanenbaum, A;
Fagan, A;
Hassenstab, J;
Mcdade, E;
Schindler, S;
... Ances, B; + view all
(2021)
Resting-State Functional Connectivity Disruption as a Pathological Biomarker in Autosomal Dominant Alzheimer Disease.
Brain Connectivity
, 11
(3)
pp. 239-249.
10.1089/brain.2020.0808.
|
Smith, EJ;
Farshim, PP;
Flomen, R;
Jones, ST;
McAteer, SJ;
Deverman, BE;
Gradinaru, V;
(2021)
Use of high-content imaging to quantify transduction of AAV-PHP viruses in the brain following systemic delivery.
Brain Communications
, 3
(2)
10.1093/braincomms/fcab105.
|
Sogorb-Esteve, A;
Colas, RA;
Dalli, J;
Rohrer, JD;
(2021)
Differential Lipid Mediator Involvement in the Different Forms of Genetic Frontotemporal Dementia: Novel Insights into Neuroinflammation.
Journal of Alzheimer's Disease
10.3233/JAD-210559.
(In press).
|
Sogorb-Esteve, A;
Swift, IJ;
Woollacott, IOC;
Warren, JD;
Zetterberg, H;
Rohrer, JD;
(2021)
Differential chemokine alteration in the variants of primary progressive aphasia-a role for neuroinflammation.
Journal of Neuroinflammation
, 18
(1)
, Article 224. 10.1186/s12974-021-02247-3.
|
Spicer, C;
Lu, C-H;
Catapano, F;
Scoto, M;
Zaharieva, I;
Malaspina, A;
Morgan, JE;
... Zhou, H; + view all
(2021)
The altered expression of neurofilament in mouse models and patients with spinal muscular atrophy.
Annals of Clinical and Translational Neurology
10.1002/acn3.51336.
(In press).
|
Srikrishna, M;
Pereira, JB;
Heckemann, RA;
Volpe, G;
van Westen, D;
Zettergren, A;
Kern, S;
... Schöll, M; + view all
(2021)
Deep learning from MRI-derived labels enables automatic brain tissue classification on human brain CT.
Neuroimage
, 244
, Article 118606. 10.1016/j.neuroimage.2021.118606.
|
Staffaroni, Adam M;
Quintana, Melanie;
Wendelberger, Barbara;
Russell, Lucy L;
Petrucelli, Leonard;
Gendron, Tania F;
Goh, Sheng‐Yang Matthew;
... Boxer, Adam L; + view all
(2021)
Disease progression models of familial frontotemporal lobar degeneration and the temporal ordering of biomarker changes in an international cohort.
Presented at: Alzheimer's Association International Conference (AAIC) 2021, Denver, CO, USA.
|
Stepanchuk, AA;
Barber, PA;
Lashley, T;
Joseph, JT;
Stys, PK;
(2021)
Quantitative detection of grey and white matter amyloid pathology using a combination of K114 and CRANAD-3 fluorescence.
Neurobiology of Disease
, 161
, Article 105540. 10.1016/j.nbd.2021.105540.
|
Stockfelt, M;
Larsson, G;
Engström, H;
Puttonen, H;
Zetterberg, H;
Blennow, K;
Sjöwall, C;
... Lundell, A-C; + view all
(2021)
Activated low-density granulocytes in peripheral and intervillous blood and neutrophil inflammation in placentas from SLE pregnancies.
Lupus Science & Medicine
, 8
(1)
, Article e000463. 10.1136/lupus-2020-000463.
|
Stockfelt, M;
Lundell, A-C;
Hetland, ML;
Østergaard, M;
Uhlig, T;
Heiberg, MS;
Haavardsholm, EA;
... Rudin, A; + view all
(2021)
Plasma interferon-alpha is associated with double-positivity for autoantibodies but is not a predictor of remission in early rheumatoid arthritis-a spin-off study of the NORD-STAR randomized clinical trial.
Arthritis Research & Therapy
, 23
, Article 189. 10.1186/s13075-021-02556-1.
|
Stokowska, A;
Bunketorp Käll, L;
Blomstrand, C;
Simrén, J;
Nilsson, M;
Zetterberg, H;
Blennow, K;
... Pekna, M; + view all
(2021)
Plasma neurofilament light chain levels predict improvement in late phase after stroke.
European Journal of Neurology
, 28
(7)
pp. 2218-2228.
10.1111/ene.14854.
|
Storm, CS;
Kia, DA;
Almramhi, MM;
Bandres-Ciga, S;
Finan, C;
Hingorani, AD;
Wood, NW;
(2021)
Finding genetically-supported drug targets for Parkinson's disease using Mendelian randomization of the druggable genome.
Nature Communications
, 12
(1)
, Article 7342. 10.1038/s41467-021-26280-1.
|
Strohmaier, S;
Homans, KM;
Hulbert, S;
Crutch, SJ;
Brotherhood, EV;
Harding, E;
Camic, PM;
(2021)
Arts-based interventions for people living with dementia: Measuring ‘in the moment’ wellbeing with the Canterbury Wellbeing Scales [version 1; peer review: awaiting peer review].
Wellcome Open Research
, 6
, Article 59. 10.12688/wellcomeopenres.16596.1.
|
Strohmaier, S;
Homans, KM;
Hulbert, S;
Crutch, SJ;
Brotherhood, EV;
Harding, E;
Camic, PM;
(2021)
Arts-based interventions for people living with dementia: Measuring ‘in the moment’ wellbeing with the Canterbury Wellbeing Scales [version 3; peer review: 2 approved].
Wellcome Open Research
, 6
p. 59.
10.12688/wellcomeopenres.16596.3.
|
Strohmaier, S;
Homans, KM;
Hulbert, S;
Crutch, SJ;
Brotherhood, EV;
Harding, E;
Camic, PM;
(2021)
Arts-based interventions for people living with dementia: Measuring ‘in the moment’ wellbeing with the Canterbury Wellbeing Scales [version 2; peer review: 1 approved].
Wellcome Open Research
, 6
, Article 59. 10.12688/wellcomeopenres.16596.2.
|
Suárez-González, A;
Savage, SA;
Bier, N;
Henry, ML;
Jokel, R;
Nickels, L;
Taylor-Rubin, C;
(2021)
Semantic variant primary progressive aphasia: Practical recommendations for treatment from 20 years of behavioural research.
Brain Sciences
, 11
(12)
, Article 1552. 10.3390/brainsci11121552.
|
Suárez-González, A;
Rajagopalan, J;
Livingston, G;
Alladi, S;
(2021)
The effect of COVID-19 isolation measures on the cognition and mental health of people living with dementia: A rapid systematic review of one year of quantitative evidence.
EClinicalMedicine
, 39
, Article 101047. 10.1016/j.eclinm.2021.101047.
|
Suárez-Pinilla, P;
Suárez-Pinilla, M;
Setien-Suero, E;
Ortiz-García de la Foz, V;
Mayoral-Van Son, J;
Vázquez-Bourgon, J;
Gómez-Revuelta, M;
... Crespo-Facorro, B; + view all
(2021)
Stability of schizophrenia diagnosis in a ten-year longitudinal study on first episode of non-affective psychosis: conclusions from the PAFIP cohort.
Acta Psychiatrica Scandinavica
, 144
(4)
pp. 342-357.
10.1111/acps.13344.
|
Suárez‐González, A;
Cassani, A;
Gopalan, R;
Stott, J;
Savage, S;
(2021)
When it is not primary progressive aphasia: A scoping review of spoken language impairment in other neurodegenerative dementias.
Alzheimer's & Dementia: Translational Research & Clinical Interventions
, 7
(1)
, Article e12205. 10.1002/trc2.12205.
|
Sullivan, R;
Yau, WY;
Chelban, V;
Rossi, S;
Dominik, N;
O'Connor, E;
Hardy, J;
... Houlden, H; + view all
(2021)
RFC1-related ataxia is a mimic of early multiple system atrophy.
Journal of Neurology, Neurosurgery & Psychiatry
10.1136/jnnp-2020-325092.
(In press).
|
Sun, X;
Wang, Q;
Blennow, K;
Zetterberg, H;
McCarthy, M;
Loewenstein, DA;
Vontell, R;
... Zhang, B; + view all
(2021)
Association of neurogranin gene expression with Alzheimer's disease pathology in the perirhinal cortex.
Alzheimer's and Dementia: Translational Research and Clinical Interventions
, 7
(1)
, Article e12162. 10.1002/trc2.12162.
|
Suwala, AK;
Stichel, D;
Schrimpf, D;
Maas, SLN;
Sill, M;
Dohmen, H;
Banan, R;
... Sahm, F; + view all
(2021)
Glioblastomas with primitive neuronal component harbor a distinct methylation and copy-number profile with inactivation of TP53, PTEN, and RB1.
Acta Neuropathologica
, 142
pp. 179-189.
10.1007/s00401-021-02302-6.
|
T
Tanaka, T;
Ruifen, JC;
Ying-Hwey, N;
Tan, CH;
Lim, CZJ;
Zhang, Y;
Stephenson, MC;
... Chen, C; + view all
(2021)
Head-to-head comparison of amplified plasmonic exosome Aβ42 platform and single-molecule array immunoassay in a memory clinic cohort.
European Journal of Neurology
, 28
(5)
pp. 1479-1489.
10.1111/ene.14704.
|
Targa, ADS;
Benitez, ID;
Dakterzada, F;
Fontenele-Araujo, J;
Minguez, O;
Zetterberg, H;
Blennow, K;
... Pinol-Ripoll, G; + view all
(2021)
The circadian rest-activity pattern predicts cognitive decline among mild-moderate Alzheimer's disease patients.
Alzheimer's Research and Therapy
, 13
, Article 161. 10.1186/s13195-021-00903-7.
|
Targa, A;
Dakterzada, F;
Benítez, I;
López, R;
Pujol, M;
Dalmases, M;
Arias, A;
... Piñol-Ripoll, G; + view all
(2021)
Decrease in sleep depth is associated with higher cerebrospinal fluid neurofilament light levels in patients with Alzheimer's disease.
Sleep
, 44
(2)
, Article zsaa147. 10.1093/sleep/zsaa147.
|
Tavakol, S;
Li, Q;
Royer, J;
Vos de Wael, R;
Larivière, S;
Lowe, A;
Paquola, C;
... Bernhardt, B; + view all
(2021)
A Structure–Function Substrate of Memory for Spatial Configurations in Medial and Lateral Temporal Cortices.
Cerebral Cortex
, 31
(7)
pp. 3213-3225.
10.1093/cercor/bhab001.
|
Teipel, S;
Bruno, D;
Plaska, CR;
Heslegrave, A;
Ramos-Cejudo, J;
Osorio, RS;
Zetterberg, H;
... Pomara, N; + view all
(2021)
Association of CSF sTREM2, a marker of microglia activation, with cholinergic basal forebrain volume in major depressive disorder.
Journal of Affective Disorders
, 293
pp. 429-434.
10.1016/j.jad.2021.06.030.
|
Tetorou, K;
Sisa, C;
Iqbal, A;
Dhillon, K;
Hristova, M;
(2021)
Current Therapies for Neonatal Hypoxic-Ischaemic and Infection-Sensitised Hypoxic-Ischaemic Brain Damage.
Frontiers in Synaptic Neuroscience
, 13
, Article 709301. 10.3389/fnsyn.2021.709301.
|
Therriault, J;
Benedet, AL;
Pascoal, TA;
Lussier, FZ;
Tissot, C;
Karikari, TK;
Ashton, NJ;
... Alzheimer’s Disease Neuroimaging Initiative; + view all
(2021)
Association of plasma P-tau181 with memory decline in non-demented adults.
Brain Communications
, 3
(3)
, Article fcab136. 10.1093/braincomms/fcab136.
|
Thijssen, EH;
La Joie, R;
Strom, A;
Fonseca, C;
Iaccarino, L;
Wolf, A;
Spina, S;
... Boxer, AL; + view all
(2021)
Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study.
The Lancet Neurology
, 20
(9)
pp. 739-752.
10.1016/S1474-4422(21)00214-3.
|
Thomas, G;
Zarkali, A;
Ryten, M;
Shmueli, K;
Gil Martinez, A;
Leyland, L;
McColgan, P;
... Weil, R; + view all
(2021)
Regional brain iron and gene expression provide insights into neurodegeneration in Parkinson’s disease.
Brain
, Article awab084. 10.1093/brain/awab084.
(In press).
|
Thompson, AGB;
Anastasiadis, P;
Druyeh, R;
Whitworth, I;
Nayak, A;
Nihat, A;
Mok, TH;
... Mead, S; + view all
(2021)
Evaluation of plasma tau and neurofilament light chain biomarkers in a 12-year clinical cohort of human prion diseases.
Molecular Psychiatry
10.1038/s41380-021-01045-w.
(In press).
|
Thust, S;
Micallef, C;
Okuchi, S;
Brandner, S;
Kumar, A;
Mankad, K;
Wastling, S;
... Shankar, A; + view all
(2021)
Imaging characteristics of H3 K27M histone-mutant diffuse midline glioma in teenagers and adults.
Quantitative Imaging in Medicine and Surgery
, 11
(1)
pp. 43-56.
10.21037/QIMS-19-954.
|
Thust, SC;
Maynard, JA;
Benenati, M;
Wastling, SJ;
Mancini, L;
Jaunmuktane, Z;
Brandner, S;
(2021)
Regional and Volumetric Parameters for Diffusion-Weighted WHO Grade II and III Glioma Genotyping: A Method Comparison.
American Journal of Neuroradiology
10.3174/ajnr.A6965.
(In press).
|
Tijms, BM;
Gobom, J;
Teunissen, C;
Dobricic, V;
Tsolaki, M;
Verhey, F;
Popp, J;
... Visser, PJ; + view all
(2021)
Csf proteomic alzheimer’s disease-predictive subtypes in cognitively intact amyloid negative individuals.
Proteomes
, 9
(3)
, Article 36. 10.3390/proteomes9030036.
|
Tiraboschi, JM;
Rojas, J;
Zetterberg, H;
Blennow, K;
Niubo, J;
Gostner, J;
Navarro-Alcaraz, A;
... Podzamczer, D; + view all
(2021)
No Changes in Human Immunodeficiency Virus (HIV) Suppression and Inflammatory Markers in Cerebrospinal Fluid in Patients Randomly Switched to Dolutegravir Plus Lamivudine (Spanish HIV/AIDS Research Network, PreEC/RIS 62).
The Journal of Infectious Diseases
, 223
(11)
pp. 1928-1933.
10.1093/infdis/jiaa645.
|
Tissot, C;
L Benedet, A;
Therriault, J;
Pascoal, TA;
Lussier, FZ;
Saha-Chaudhuri, P;
Chamoun, M;
... Alzheimer’s Disease Neuroimaging Initiative; + view all
(2021)
Plasma pTau181 predicts cortical brain atrophy in aging and Alzheimer's disease.
Alzheimer's Research & Therapy
, 13
, Article 69. 10.1186/s13195-021-00802-x.
|
Tjörnstrand, A;
Casar‐Borota, O;
Heurling, K;
Schöll, M;
Gjertsson, P;
Ragnarsson, O;
Filipsson Nyström, H;
(2021)
Pre‐ and postoperative 68Ga‐DOTATOC positron emission tomography for hormone‐secreting pituitary neuroendocrine tumors.
Clinical Endocrinology
, 94
(6)
pp. 956-967.
10.1111/cen.14425.
|
Tobieson, L;
Zetterberg, H;
Blennow, K;
Marklund, N;
(2021)
Extracellular fluid, cerebrospinal fluid and plasma biomarkers of axonal and neuronal injury following intracerebral hemorrhage.
Scientific Reports
, 11
, Article 16950. 10.1038/s41598-021-96364-x.
|
Tofiq, A;
Zetterberg, H;
Blennow, K;
Basun, H;
Cederholm, T;
Eriksdotter, M;
Faxén-Irving, G;
... Freund-Levi, Y; + view all
(2021)
Effects of Peroral Omega-3 Fatty Acid Supplementation on Cerebrospinal Fluid Biomarkers in Patients with Alzheimer’s Disease: A Randomized Controlled Trial—The OmegAD Study.
Journal of Alzheimer's Disease
, 83
(3)
pp. 1291-1301.
10.3233/JAD-210007.
|
Tookey, SA;
Greaves, CV;
Rohrer, JD;
Stott, J;
(2021)
Specific support needs and experiences of carers of people with frontotemporal dementia: A systematic review.
Dementia
10.1177/14713012211022982.
(In press).
|
Toombs, J;
Zetterberg, H;
(2021)
Untangling the tau microtubule-binding region.
Brain
, 144
(2)
pp. 359-362.
10.1093/brain/awaa468.
|
Toppala, S;
Ekblad, LL;
Tuisku, J;
Helin, S;
Johansson, JJ;
Laine, H;
Löyttyniemi, E;
... Rinne, JO; + view all
(2021)
Association of Early Beta-amyloid Accumulation and Neuroinflammation Measured with [11C]PBR28 in Elderly Individuals Without Dementia.
Neurology
, 96
(12)
e1608-e1619.
10.1212/WNL.0000000000011612.
|
Tortelli, R;
Rodrigues, F;
Wild, E;
(2021)
The use of wearable/portable digital sensors in Huntington’s disease: a systematic review.
Parkinsonism & Related Disorders
10.1016/j.parkreldis.2021.01.006.
(In press).
|
Tosh, JL;
Rhymes, ER;
Mumford, P;
Whittaker, HT;
Pulford, LJ;
Noy, SJ;
Cleverley, K;
... Wiseman, FK; + view all
(2021)
Genetic dissection of down syndrome-associated alterations in APP/amyloid-β biology using mouse models.
Scientific Reports
, 11
(1)
, Article 5736. 10.1038/s41598-021-85062-3.
|
Tosun, D;
Veitch, D;
Aisen, P;
Jack, CR;
Jagust, WJ;
Petersen, RC;
Saykin, AJ;
... Weiner, MW; + view all
(2021)
Detection of β-amyloid positivity in Alzheimer's Disease Neuroimaging Initiative participants with demographics, cognition, MRI and plasma biomarkers.
Brain Communications
, 3
(2)
, Article fcab008. 10.1093/braincomms/fcab008.
|
Tsitsopoulos, PP;
Holmström, U;
Blennow, K;
Zetterberg, H;
Marklund, N;
(2021)
Cerebrospinal fluid biomarkers of glial and axonal injury in cervical spondylotic myelopathy.
Journal of Neurosurgery: Spine
pp. 1-10.
10.3171/2020.8.SPINE20965.
(In press).
|
U
Umek, T;
Olsson, T;
Gissberg, O;
Saher, O;
Zaghloul, EM;
Lundin, KE;
Wengel, J;
... Zain, R; + view all
(2021)
Oligonucleotides Targeting DNA Repeats Downregulate Huntingtin Gene Expression in Huntington's Patient-Derived Neural Model System.
Nucleic Acid Therapeutics
10.1089/nat.2021.0021.
(In press).
|
V
van der Ende, EL;
Bron, EE;
Poos, JM;
Jiskoot, LC;
Panman, JL;
Papma, JM;
Meeter, LH;
... GENFI consortium; + view all
(2021)
A data-driven disease progression model of fluid biomarkers in genetic frontotemporal dementia.
Brain
10.1093/brain/awab382.
(In press).
|
Van Hulle, C;
Jonaitis, EM;
Betthauser, TJ;
Batrla, R;
Wild, N;
Kollmorgen, G;
Andreasson, U;
... Blennow, K; + view all
(2021)
An examination of a novel multipanel of CSF biomarkers in the Alzheimer's disease clinical and pathological continuum.
Alzheimer's & Dementia
, 17
(3)
pp. 431-445.
10.1002/alz.12204.
|
van Rheenen, W;
van der Spek, RAA;
Bakker, MK;
van Vugt, JJFA;
Hop, PJ;
Zwamborn, RAJ;
de Klein, N;
... Veldink, JH; + view all
(2021)
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology.
Nature Genetics
, 53
(12)
pp. 1636-1648.
10.1038/s41588-021-00973-1.
|
Van't Hooft, JJ;
Pijnenburg, YAL;
Sikkes, SAM;
Scheltens, P;
Spikman, JM;
Jaschke, AC;
Warren, JD;
(2021)
Frontotemporal dementia, music perception and social cognition share neurobiological circuits: A meta-analysis.
Brain and Cognition
, 148
, Article 105660. 10.1016/j.bandc.2020.105660.
(In press).
|
Vavouraki, N;
Tomkins, JE;
Kara, E;
Houlden, H;
Hardy, J;
Tindall, MJ;
Lewis, PA;
(2021)
Integrating protein networks and machine learning for disease stratification in the Hereditary Spastic Paraplegias.
iScience
, Article 102484. 10.1016/j.isci.2021.102484.
(In press).
|
Veale, T;
Malone, IB;
Poole, T;
Parker, TD;
Slattery, CF;
Paterson, RW;
Foulkes, AJM;
... Cash, DM; + view all
(2021)
Loss and dispersion of superficial white matter in Alzheimer's disease: a diffusion MRI study.
Brain Communications
, 3
(4)
, Article fcab272. 10.1093/braincomms/fcab272.
|
Veale, Thomas;
Parker, Christopher S;
Bocchetta, Martina;
Malone, Ian B;
Slattery, Catherine F;
Schott, Jonathan M;
Fox, Nick C;
... Cash, David M; + view all
(2021)
Atrophy and partial volume related bias in cortical region of interest NODDI metrics.
Presented at: Alzheimer's Association International Conference (AAIC) 2021, Denver, CO, USA.
|
Vera, Jaime H;
Eftychiou, Nicholas;
Schuerer, Matti;
Rullmann, Michael;
Barthel, Henryk;
Sabri, Osama;
Gisslen, Magnus;
... Dizdarevic, Sabina; + view all
(2021)
Clinical Utility of β-Amyloid PET Imaging in People Living With HIV With Cognitive Symptoms.
JAIDS: Journal of Acquired Immune Deficiency Syndromes
, 87
(2)
pp. 826-833.
10.1097/QAI.0000000000002648.
|
Verberk, IMW;
Misdorp, EO;
Koelewijn, J;
Ball, AJ;
Blennow, K;
Dage, JL;
Fandos, N;
... Teunissen, CE; + view all
(2021)
Characterization of pre-analytical sample handling effects on a panel of Alzheimer's disease–related blood-based biomarkers: Results from the Standardization of Alzheimer's Blood Biomarkers (SABB) working group.
Alzheimer's and Dementia
10.1002/alz.12510.
|
Verdi, S;
Marquand, AF;
Schott, JM;
Cole, JH;
(2021)
Beyond the average patient: how neuroimaging models can address heterogeneity in dementia.
Brain
10.1093/brain/awab165.
(In press).
|
Vergallo, A;
Lemercier, P;
Cavedo, E;
Lista, S;
Vanmechelen, E;
De Vos, A;
Zetterberg, H;
... INSIGHT-preAD study group, and the Alzheimer Precision Medicine; + view all
(2021)
Plasma β-secretase1 concentrations correlate with basal forebrain atrophy and neurodegeneration in cognitively healthy individuals at risk for AD.
Alzheimer's & Dementia
, 17
(4)
pp. 629-640.
10.1002/alz.12228.
|
Verma, A;
Ebanks, K;
Fok, C-Y;
Lewis, P;
Bettencourt, C;
Bandopadhyay, R;
(2021)
In silico comparative analysis of LRRK2 interactomes from brain, kidney and lung.
Brain Research
, 1765
, Article 147503. 10.1016/j.brainres.2021.147503.
|
Vilor-Tejedor, N;
Ciampa, I;
Operto, G;
Falcón, C;
Suárez-Calvet, M;
Crous-Bou, M;
Shekari, M;
... Vilanova, M; + view all
(2021)
Perivascular spaces are associated with tau pathophysiology and synaptic dysfunction in early Alzheimer’s continuum.
Alzheimer's Research and Therapy
, 13
, Article 135. 10.1186/s13195-021-00878-5.
|
Vinel, C;
Rosser, G;
Guglielmi, L;
Constantinou, M;
Pomella, N;
Zhang, X;
Boot, JR;
... Marino, S; + view all
(2021)
Comparative epigenetic analysis of tumour initiating cells and syngeneic EPSC-derived neural stem cells in glioblastoma.
Nature Communications
, 12
(1)
, Article 6130. 10.1038/s41467-021-26297-6.
|
Vogel, JW;
Young, AL;
Oxtoby, NP;
Smith, R;
Ossenkoppele, R;
Strandberg, OT;
La Joie, R;
... Hansson, O; + view all
(2021)
Four distinct trajectories of tau deposition identified in Alzheimer's disease.
Nature Medicine
, 27
pp. 871-881.
10.1038/s41591-021-01309-6.
|
Volkmer, A;
Spector, A;
Swinburn, K;
Warren, J;
Beeke, S;
(2021)
Using the Medical Research Council Framework and public involvement for the development of a communication partner training intervention for people with primary progressive aphasia (PPA): Better Conversations with PPA.
BMC Geriatrics
(In press).
|
W
Wadsworth, JDF;
Joiner, S;
Linehan, JM;
Jack, K;
Al-Doujaily, H;
Costa, H;
Ingold, T;
... Collinge, J; + view all
(2021)
Humanised transgenic mice are resistant to chronic wasting disease prions from Norwegian reindeer and moose.
The Journal of Infectious Diseases
10.1093/infdis/jiab033.
(In press).
|
Walgrave, H;
Balusu, S;
Snoeck, S;
Vanden Eynden, E;
Craessaerts, K;
Thrupp, N;
Wolfs, L;
... Salta, E; + view all
(2021)
Restoring miR-132 expression rescues adult hippocampal neurogenesis and memory deficits in Alzheimer's disease.
Cell Stem Cell
10.1016/j.stem.2021.05.001.
(In press).
|
Walker, N;
Crutch, SJ;
West, J;
Jones, FW;
Brotherhood, EV;
Harding, E;
Camic, PM;
(2021)
Singing and music making: physiological responses across early to later stages of dementia [version 2; peer review: 1 approved with reservations].
Wellcome Open Research
, 6
, Article 150. 10.12688/wellcomeopenres.16856.2.
|
Walker, N;
Crutch, SJ;
West, J;
Jones, FW;
Brotherhood, EV;
Harding, E;
Camic, PM;
(2021)
Singing and music making: physiological responses across early to later stages of dementia [version 1; peer review: awaiting peer review].
Wellcome Open Research
, 6
, Article 150. 10.12688/wellcomeopenres.16856.1.
|
Wall, A;
Anger, O;
Jood, K;
Blomstrand, C;
Andreasson, U;
Blennow, K;
Zetterberg, H;
... Svensson, J; + view all
(2021)
Circulating granulocyte colony-stimulating factor and functional outcome after ischemic stroke: an observational study.
Neurological Research
10.1080/01616412.2021.1948766.
(In press).
|
Walsh, P;
Sudre, CH;
Fiford, CM;
Ryan, NS;
Lashley, T;
Frost, C;
Barnes, J;
(2021)
The age-dependent associations of white matter hyperintensities and neurofilament light in early- and late-stage Alzheimer's disease.
Neurobiology of Aging
, 97
pp. 10-17.
10.1016/j.neurobiolaging.2020.09.008.
|
Wang, H;
Robinson, JL;
Kocabas, P;
Gustafsson, J;
Anton, M;
Cholley, P-E;
Huang, S;
... Nielsen, J; + view all
(2021)
Genome-scale metabolic network reconstruction of model animals as a platform for translational research.
Proceedings of the National Academy of Sciences
, 118
(30)
, Article e2102344118. 10.1073/pnas.2102344118.
|
Weber, TA;
Lundkvist, J;
Wanngren, J;
Kvartsberg, H;
Jin, S;
Larssen, P;
Wu, D;
... Karlström, H; + view all
(2021)
γ-Secretase modulators show selectivity for γ-secretase–mediated amyloid precursor protein intramembrane processing.
Journal of Cellular and Molecular Medicine
10.1111/jcmm.17146.
(In press).
|
Weil, RS;
Lees, AJ;
(2021)
How to understand it: Visual hallucinations.
Practical Neurology
, 21
(4)
pp. 327-332.
10.1136/practneurol-2021-003016.
|
Weinhofer, I;
Rommer, P;
Zierfuss, B;
Altmann, P;
Foiani, M;
Heslegrave, A;
Zetterberg, H;
... Berger, J; + view all
(2021)
Neurofilament light chain as a potential biomarker for monitoring neurodegeneration in X-linked adrenoleukodystrophy.
Nature Communications
, 12
, Article 1816. 10.1038/s41467-021-22114-2.
|
Wiberg, S;
Holmgaard, F;
Blennow, K;
Nilsson, JC;
Kjaergaard, J;
Wanscher, M;
Langkilde, AR;
... Vedel, AG; + view all
(2021)
Associations between mean arterial pressure during cardiopulmonary bypass and biomarkers of cerebral injury in patients undergoing cardiac surgery: secondary results from a randomized controlled trial.
Interactive CardioVascular and Thoracic Surgery
, 32
(2)
pp. 229-235.
10.1093/icvts/ivaa264.
|
Wightman, DP;
Jansen, IE;
Savage, JE;
Shadrin, AA;
Bahrami, S;
Holland, D;
Rongve, A;
... Posthuma, D; + view all
(2021)
A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer's disease.
Nature Genetics
, 53
(9)
pp. 1276-1282.
10.1038/s41588-021-00921-z.
|
Wijeratne, PA;
Garbarino, S;
Gregory, S;
Johnson, EB;
Scahill, RI;
Paulsen, JS;
Tabrizi, SJ;
... Alexander, DC; + view all
(2021)
Revealing the Timeline of Structural MRI Changes in Premanifest to Manifest Huntington Disease.
Neurology Genetics
, 7
(5)
e617.
10.1212/nxg.0000000000000617.
|
Wijeratne, PA;
Johnson, EB;
Gregory, S;
Georgiou-Karistianis, N;
Paulsen, JS;
Scahill, RI;
Tabrizi, SJ;
(2021)
A Multi-Study Model-Based Evaluation of the Sequence of Imaging and Clinical Biomarker Changes in Huntington's Disease.
Frontiers in Big Data
, 4
, Article 662200. 10.3389/fdata.2021.662200.
|
Wilke, C;
Reich, S;
van Swieten, JC;
Borroni, B;
Sanchez-Valle, R;
Moreno, F;
Laforce, R;
... Synofzik, M; + view all
(2021)
Stratifying the Presymptomatic Phase of Genetic Frontotemporal Dementia by Serum NfL and pNfH: A Longitudinal Multicentre Study.
Annals of Neurology
10.1002/ana.26265.
(In press).
|
Williams, T;
Zetterberg, H;
Chataway, J;
(2021)
Serum Neurofilament Light concentrations are not associated with renal function in secondary progressive multiple sclerosis.
Biomarkers in Neuropsychiatry
, 5
, Article 100044. 10.1016/j.bionps.2021.100044.
|
Willumsen, N;
Poole, T;
Nicholas, JM;
Fox, NC;
Ryan, NS;
Lashley, T;
(2021)
Variability in the type and layer distribution of cortical A beta pathology in familial Alzheimer's disease.
Brain Pathology
10.1111/bpa.13009.
(In press).
|
Wu, Y;
Whittaker, HT;
Noy, S;
Cleverley, K;
Brault, V;
Herault, Y;
Fisher, EMC;
(2021)
The effects of Cstb duplication on APP/amyloid-β pathology and cathepsin B activity in a mouse model.
PLoS One
, 16
(7)
, Article e0242236. 10.1371/journal.pone.0242236.
|
X
Xiromerisiou, G;
Bourinaris, T;
Houlden, H;
Lewis, PA;
Senkevich, K;
Hammer, M;
Federoff, M;
... Hardy, J; + view all
(2021)
SORL1 mutation in a Greek family with Parkinson's disease and dementia.
Annals of Clinical and Translational Neurology
10.1002/acn3.51433.
(In press).
|
Xu, J;
Green, R;
Kim, M;
Lord, J;
Ebshiana, A;
Westwood, S;
Baird, AL;
... On Behalf Of The European Medical Information Framework Consorti; + view all
(2021)
Sex-Specific Metabolic Pathways Were Associated with Alzheimer's Disease (AD) Endophenotypes in the European Medical Information Framework for AD Multimodal Biomarker Discovery Cohort.
Biomedicines
, 9
(11)
, Article 1610. 10.3390/biomedicines9111610.
|
Xu, L;
Ramadan, S;
Akingbade, OE;
Zhang, Y;
Alodan, S;
Graham, N;
Zimmerman, KA;
... Li, B; + view all
(2021)
Detection of Glial Fibrillary Acidic Protein in Patient Plasma Using On-Chip Graphene Field-Effect Biosensors, in Comparison with ELISA and Single-Molecule Array.
ACS Sensors
10.1021/acssensors.1c02232.
(In press).
|
Y
Yap, SY;
Frias, B;
Wren, MC;
Schöll, M;
Fox, NC;
Årstad, E;
Lashley, T;
(2021)
Discriminatory ability of next-generation tau PET tracers for Alzheimer's disease.
Brain
10.1093/brain/awab120.
(In press).
|
Yau, WY;
Chen, Z;
Sullivan, R;
Vandrovcova, J;
Houlden, H;
(2021)
Reply: Genetic heterogeneity of neuronal intranuclear inclusion disease. What about the infantile variant?
Annals of Clinical and Translational Neurology
, 8
(4)
pp. 1002-1004.
10.1002/acn3.51330.
|
Young, AL;
Bocchetta, M;
Russell, LL;
Convery, RS;
Peakman, G;
Todd, E;
Cash, DM;
... Genetic FTD Initiative (GENFI); + view all
(2021)
Characterizing the Clinical Features and Atrophy Patterns of MAPT-Related Frontotemporal Dementia With Disease Progression Modeling.
Neurology
10.1212/WNL.0000000000012410.
(In press).
|
Z
Zareba-Paslawska, J;
Patra, K;
Kluzer, L;
Revesz, T;
Svenningsson, P;
(2021)
Tau Isoform-Driven CBD Pathology Transmission in Oligodendrocytes in Humanized Tau Mice.
Frontiers in Neurology
, 11
, Article 589471. 10.3389/fneur.2020.589471.
|
Zarkali, A;
McColgan, P;
Leyland, L;
Lees, A;
Weil, R;
(2021)
Longitudinal thalamic white and gray matter changes associated with visual hallucinations in Parkinson’s disease.
Journal of Neurology, Neurosurgery and Psychiatry
, 93
pp. 169-179.
10.1136/jnnp-2021-326630.
|
Zarkali, A;
Weil, RS;
(2021)
Beyond dopamine: further evidence of cholinergic dysfunction in Parkinson's disease.
European Journal of Neuroscience
, 53
(11)
pp. 3740-3742.
10.1111/ejn.15269.
|
Zarkali, Angeliki;
(2021)
The Neural Correlates of Visual Hallucinations in Parkinson's Disease.
Doctoral thesis (Ph.D), UCL (University College London).
|
Zarkali, A;
McColgan, P;
Leyland, L;
Lees, A;
Weil, R;
(2021)
Visual dysfunction predicts cognitive impairment and white matter degeneration in Parkinson’s disease.
Movement Disorders
(In press).
|
Zarkali, A;
McColgan, P;
Leyland, L-A;
Lees, AJ;
Rees, G;
Weil, RS;
(2021)
Organisational and neuromodulatory underpinnings of structural-functional connectivity decoupling in patients with Parkinson's disease.
Communications Biology
, 4
, Article 86. 10.1038/s42003-020-01622-9.
|
Zerr, I;
Villar-Piqué, A;
Hermann, P;
Schmitz, M;
Varges, D;
Ferrer, I;
Riggert, J;
... Llorens, F; + view all
(2021)
Diagnostic and prognostic value of plasma neurofilament light and total-tau in sporadic Creutzfeldt-Jakob disease.
Alzheimer's Research & Therapy
, 13
(1)
, Article 86. 10.1186/s13195-021-00815-6.
|
Zetterberg, H;
(2021)
Glial fibrillary acidic protein: a blood biomarker to differentiate neurodegenerative from psychiatric diseases.
Journal of Neurology, Neurosurgery and Psychiatry
10.1136/jnnp-2021-326994.
(In press).
|
Zetterberg, H;
Stomrud, E;
(2021)
Alzheimer's disease in primary care: new tools for improved and simplified diagnostics.
Journal of Internal Medicine
, 290
(2)
pp. 477-479.
10.1111/joim.13249.
|
Zetterberg, H;
Bendlin, BB;
(2021)
Neurodegenerative dementias: screening for major threats to healthy longevity with blood biomarkers.
The Lancet Healthy Longevity
, 2
(2)
e58-e59.
10.1016/S2666-7568(21)00009-X.
|
Zetterberg, H;
Blennow, K;
(2021)
Moving fluid biomarkers for Alzheimer's disease from research tools to routine clinical diagnostics.
Molecular Neurodegeneration
, 16
, Article 10. 10.1186/s13024-021-00430-x.
|
Zettergren, A;
Lord, J;
Ashton, NJ;
Benedet, AL;
Karikari, TK;
Lantero Rodriguez, J;
Snellman, A;
... Blennow, K; + view all
(2021)
Association between polygenic risk score of Alzheimer’s disease and plasma phosphorylated tau in individuals from the Alzheimer’s Disease Neuroimaging Initiative.
Alzheimer's Research and Therapy
, 13
, Article 17. 10.1186/s13195-020-00754-8.
|
Zhang, JV;
Irwin, DJ;
Blennow, K;
Zetterberg, H;
Lee, EB;
Shaw, LM;
Rascovsky, K;
... Grossman, M; + view all
(2021)
Neurofilament Light Chain Related to Longitudinal Decline in Frontotemporal Lobar Degeneration.
Neurology Clinical Practice
, 11
(2)
pp. 105-116.
10.1212/CPJ.0000000000000959.
|
Zhen-Yi, AO;
Byrne, L;
Brogueira Rodrigues, F;
Tortelli, R;
Johnson, E;
Foiani, M;
Arridge, M;
... Wild, E; + view all
(2021)
Brain-derived neurotrophic factor in cerebrospinal fluid and plasma is not a biomarker for Huntington’s disease.
Scientific Reports
, 11
, Article 3481. 10.1038/s41598-021-83000-x.
|
Zheng, T;
Ghasemi, DR;
Okonechnikov, K;
Korshunov, A;
Sill, M;
Maass, KK;
Benites Goncalves da Silva, P;
... Pajtler, KW; + view all
(2021)
Cross-Species Genomics Reveals Oncogenic Dependencies in ZFTA/C11orf95 Fusion–Positive Supratentorial Ependymomas.
Cancer Discovery
, 11
(9)
pp. 2230-2247.
10.1158/2159-8290.CD-20-0963.
|
Zhou, Y;
Peskett, TR;
Landles, C;
Warner, JB;
Sathasivam, K;
Smith, EJ;
Chen, S;
... Saibil, HR; + view all
(2021)
Correlative light and electron microscopy suggests that mutant huntingtin dysregulates the endolysosomal pathway in presymptomatic Huntington’s disease.
Acta Neuropathologica Communications
, 9
, Article 70. 10.1186/s40478-021-01172-z.
|
Zimmerman, KA;
Laverse, E;
Samra, R;
Yanez Lopez, M;
Jolly, AE;
Bourke, NJ;
Graham, NSN;
... Sharp, DJ; + view all
(2021)
White matter abnormalities in active elite adult rugby players.
Brain Communications
, 3
(3)
, Article fcab133. 10.1093/braincomms/fcab133.
|
zu Eulenburg, P;
Buchheim, J-I;
Ashton, NJ;
Vassilieva, G;
Blennow, K;
Zetterberg, H;
Chouker, A;
(2021)
Changes in Blood Biomarkers of Brain Injury and Degeneration Following Long-Duration Spaceflight.
JAMA Neurology
10.1001/jamaneurol.2021.3589.
(In press).
|
Ö
Öhman, F;
Hassenstab, J;
Berron, D;
Schöll, M;
Papp, KV;
(2021)
Current advances in digital cognitive assessment for preclinical Alzheimer's disease.
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
, 13
(1)
, Article e12217. 10.1002/dad2.12217.
|
Öijerstedt, L;
Andersson, C;
Jelic, V;
van Swieten, JC;
Jiskoot, LC;
Seelaar, H;
Borroni, B;
... Genetic Frontotemporal Dementia Initiative (GENFI), .; + view all
(2021)
Practice effects in genetic frontotemporal dementia and at-risk individuals: a GENFI study.
Journal of neurology, neurosurgery, and psychiatry
10.1136/jnnp-2021-327005.
(In press).
|